<SEC-DOCUMENT>0001683168-23-001214.txt : 20230301
<SEC-HEADER>0001683168-23-001214.hdr.sgml : 20230301
<ACCEPTANCE-DATETIME>20230301143108
ACCESSION NUMBER:		0001683168-23-001214
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20230228
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230301
DATE AS OF CHANGE:		20230301

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		23692662

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>radnet_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:RDNT="http://radnet.com/20230228">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_RDNT_radnet.com_20230228 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20230228_20230228 -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0000790526 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-02-28to2023-02-28" name="dei:EntityCentralIndexKey">0000790526</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-02-28to2023-02-28" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="rdnt-20230228.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-02-28to2023-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-28</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">UNITED
STATES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Washington,
D.C. 20549</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>FORM
<span id="xdx_90D_edei--DocumentType_c20230228__20230228_zfYGNSpxvVo7"><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Date
of Report (Date of earliest event reported <span id="xdx_90E_edei--DocumentPeriodEndDate_c20230228__20230228_zcXIE8SSIVZ5"><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">February
28, 2023</ix:nonNumeric></span></span>)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">_______________________________________________</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_903_edei--EntityRegistrantName_c20230228__20230228_zsBI1QPCSMM2" style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" name="dei:EntityRegistrantName">RadNet,
Inc.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center; padding-left: 10pt; width: 32%"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20230228__20230228_zjhXgcR03D26" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; padding-left: 10pt; width: 32%"><span id="xdx_907_edei--EntityFileNumber_c20230228__20230228_zzBaWXTjjVKj" style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" name="dei:EntityFileNumber">001-33307</ix:nonNumeric></b></span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 32%"><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20230228__20230228_zw12FXq1Fx46" style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" name="dei:EntityTaxIdentificationNumber">13-3326724</ix:nonNumeric></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">(State or other jurisdiction<br />
    of incorporation)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">(Commission File Number)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">(IRS Employer Identification No.)</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.9pt; text-indent: -16.75pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_90C_edei--EntityAddressAddressLine1_c20230228__20230228_z2wXfnKIUbxd"><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" name="dei:EntityAddressAddressLine1">1510 Cotner Avenue</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_901_edei--EntityAddressCityOrTown_c20230228__20230228_zqaIdF8gc2L2"><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" name="dei:EntityAddressCityOrTown">Los Angeles</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20230228__20230228_zox3bEdTFR0j"><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span>
<span id="xdx_900_edei--EntityAddressPostalZipCode_c20230228__20230228_zTnSno6HwRyh"><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" name="dei:EntityAddressPostalZipCode">90025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of Principal Executive
Offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(<span id="xdx_908_edei--CityAreaCode_c20230228__20230228_zXAyeGFij2Pa"><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" name="dei:CityAreaCode">310</ix:nonNumeric></span>) <span id="xdx_903_edei--LocalPhoneNumber_c20230228__20230228_zGdG2vqWS69g"><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" name="dei:LocalPhoneNumber">478-7808</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Registrant&#8217;s Telephone
Number, Including Area Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">_______________________________________________</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span id="xdx_905_edei--WrittenCommunications_c20230228__20230228_zi3MDmRqZXFk" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif">Written
                                            communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span id="xdx_900_edei--SolicitingMaterial_c20230228__20230228_zLIS5R4y8icj" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif">Soliciting
                                            material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span id="xdx_90B_edei--PreCommencementTenderOffer_c20230228__20230228_zs8M55rBBK4l" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif">Pre-commencement
                                            communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span id="xdx_90D_edei--PreCommencementIssuerTenderOffer_c20230228__20230228_zbldYR3lzEx8" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif">Pre-commencement
                                            communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-size: 10pt; text-align: center; width: 33%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
                                            of each class</b></span></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-size: 10pt; text-align: center; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-size: 10pt; text-align: center; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
<tr>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center"><span id="xdx_909_edei--Security12bTitle_c20230228__20230228_zXUoRT9jFxO4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" name="dei:Security12bTitle">Common
    Stock, $0.0001 par value</ix:nonNumeric></span></td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span id="xdx_901_edei--TradingSymbol_c20230228__20230228_zWaA58pXGjUk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" name="dei:TradingSymbol">RDNT</ix:nonNumeric></span></td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center"><span id="xdx_90A_edei--SecurityExchangeName_c20230228__20230228_zqdw2Zsrcf8b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ
    Global Market</ix:nonNumeric></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Emerging
growth company <span id="xdx_90F_edei--EntityEmergingGrowthCompany_c20230228__20230228_zg7b3geAFGdb"><ix:nonNumeric contextRef="From2023-02-28to2023-02-28" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 125.95pt"><b>Item 2.02</b></td><td><b>RESULTS OF OPERATIONS AND FINANCIAL CONDITION</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 28, 2023 RadNet,
Inc. (&#8220;RadNet&#8221;) issued a press release and held a conference call regarding our 2022 financial results for the fourth quarter
and full fiscal year ended December 31, 2022. A copy of the press release is furnished as Exhibit 99.1 and a copy of the transcript of
the conference call is furnished as Exhibit 99.2 to this Current Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information in this Current
Report, including Exhibit 99.1 and Exhibit 99.2 is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section
18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The information in this Current Report,
including Exhibit 99.1 and Exhibit 99.2 shall not be incorporated by reference into any registration statement or other document filed
with the Commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="width: 1in"><b>Item 9.01.</b></td>
  <td><b>Financial Statements and Exhibits.</b></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt">(d)<span style="font-size: 10pt"><b>&#160;&#160;&#160;
</b></span>Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; background-color: white; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 18%"><span style="text-decoration: underline"><b>Exhibit Number</b></span></td>
    <td style="width: 82%"><span style="text-decoration: underline"><b>Description of Exhibit</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>99.1</td>
    <td><a href="radnet_ex9901.htm">Press Release dated February 28, 2023 relating to RadNet, Inc.&#8217;s financial
results for the quarter and full fiscal year ended December 31, 2022<br />
</a></td></tr>
  <tr style="vertical-align: top">
    <td>99.2</td>
    <td><a href="radnet_ex9902.htm">Transcript of conference call</a></td></tr>
  <tr style="vertical-align: top">
    <td>104</td>
    <td>Cover Page Interactive Data File (embedded within the inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><b>RADNET, INC.</b></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">Date: March 1, 2023</td>
    <td style="width: 5%">By:</td>
    <td style="border-bottom: Black 1pt solid; width: 45%">/s/ Mark D. Stolper</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Name:</td>
    <td>Mark D. Stolper</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Title:</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer</p></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 21.15pt 0pt 27.2pt; text-align: center">EXHIBIT INDEX</p>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; background-color: white; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 18%"><span style="text-decoration: underline"><b>Exhibit Number</b></span></td>
    <td style="width: 82%"><span style="text-decoration: underline"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>99.1</td>
    <td><a href="radnet_ex9901.htm">Press Release dated February 28, 2023.</a></td></tr>
  <tr style="vertical-align: top">
    <td>99.2</td>
    <td>Transcript of conference call.</td></tr>
  <tr style="vertical-align: top">
    <td>104</td>
    <td>Cover Page Interactive Data File (embedded within the inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>


</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LdpNBbdLh4o4ZYwh3hYXpbg1I61/j+Rb2m2IIRCSc74cIUZiQ2tdI8NpWWRQYtPWyiEUeEFGc0bvSLe7BPws8KqtY2Vcv/7AlDyDnpmPY+XvvfOhLVYJyMVExpMoBDlL5BTyvQg6PSVz0RUap1UNylSQM7Ws0Sl+Dx9K9SJDzbtPOiJbTSaBcCwH+QORDCM40EM9iW8WsiwVwaivQGyY7m0Xc7eOGljV2PgsO6D/Dr7iWkkg -->

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>radnet_ex9901.htm
<DESCRIPTION>EARNINGS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><IMG SRC="image_004.jpg" ALT="" STYLE="height: 92px; width: 176px"></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR IMMEDIATE RELEASE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><B>RadNet Reports Fourth Quarter 2022 Results, Including Record Revenue
and Adjusted EBITDA<SUP>(1)</SUP>, and Releases 2023 Financial Guidance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Revenue increased 15.2% to a record of $383.9 million in the fourth quarter
of 2022 from $333.1 million in the fourth quarter of 2021; Excluding Revenue from the Artificial Intelligence (&ldquo;AI&rdquo;) reporting
segment, Revenue from the Imaging Centers reporting segment in the fourth quarter of 2022 was $382.5 million, an increase of 15.1% from
last year&rsquo;s fourth quarter</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Excluding losses from our AI reporting segment and adjusting for Provider
Relieve Funding Received in the fourth quarter of 2021, Adjusted EBITDA<SUP>(1)</SUP> from the Imaging Centers reporting segment was a
record $61.6 million as compared with $52.0 million in the fourth quarter of 2021, an increase of 18.4%</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Adjusting for unusual or one-time items impacting Net Income in the quarter,
Adjusted Earnings Per Share<SUP>(3)</SUP> was $0.11 for the fourth quarter of 2022; This compares with Adjusted Earnings Per Share<SUP>(3)</SUP>
of $0.10 for the fourth quarter of 2021 </I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Aggregate procedural volumes increased 8.0% and same-center procedural
volumes increased 3.6% compared to the fourth quarter of 2021</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>After a successful pilot in Delaware, RadNet is implementing its Enhanced
Breast Cancer Detection (EBCD) AI-powered mammography offering across all of its markets </I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>RadNet announces 2023 guidance ranges, anticipating increases in Revenue,
Adjusted EBITDA<SUP>(1)</SUP> and Free Cash Flow<SUP>(2)</SUP> for 2023 over 2022</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>LOS ANGELES, California, February 28, 2023
&ndash; RadNet, Inc. (NASDAQ: RDNT),</B> a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic
imaging services through a network of 357 owned and/or operated outpatient imaging centers, today reported financial results for its fourth
quarter and full year ended December 31, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Financial Results</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Fourth Quarter Report:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief Executive
Officer of RadNet, commented, &ldquo;I am very pleased with our strong performance in the fourth quarter, which enabled us to exceed our
2022 full-year revised guidance ranges for Revenue and Adjusted EBITDA<SUP>(1)</SUP>. Contributing to our record Revenue and Adjusted
EBITDA<SUP>(1)</SUP> in the quarter was a combination of high procedural demand for our services and improving conditions in our labor
markets. Since September, we have been more successful in filling open positions and staffing our locations, enabling us to better meet
the increasing demand we are experiencing for our services in virtually all markets in which we operate.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Throughout 2022, we carefully managed our
liquidity and financial leverage. At year-end 2022, we had a cash balance of over $127 million and our net debt leverage ratio remained
under 3.5 times Adjusted EBITDA<SUP>(1)</SUP>. Our Days Sales Outstanding (DSOs) remained low at 39 days as of December 31, 2022, helping
to contribute to our strong cash flow in the quarter and throughout 2022,&rdquo; Dr. Berger noted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Moving into 2023, the demand for diagnostic
imaging remains robust and is growing. Our solid financial position and operating model have presented us with targeted opportunities
to expand our business, particularly through the construction of new centers to meet the growing demand and utilization in strategic markets.
Currently, we have over a dozen centers in various stages of construction and development, and we believe these sites should be positive
contributors to our performance in 2023. As the imaging center market further consolidates, we continue to see opportunities for tuck-in
acquisitions in virtually all of RadNet markets at prices consistent with our historical discipline. Furthermore, throughout 2023, we
expect to expand existing health system joint ventures and partnerships and establish new ones,&rdquo; added Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger concluded, &ldquo;We are also making
significant strides in commercializing and monetizing our AI investments. Specifically, in November 2022, we began an implementation of
our Enhanced Breast Cancer Diagnostic (EBCD) mammography program, where we are offering novel AI-enhanced mammography services to women
in conjunction with their annual breast cancer screening exams for an additional fee. We expect that this offering will be available in
all RadNet mammography centers by the end of the summer of 2023. Based upon early adoption data from several of our east coast markets,
we are anticipating our losses from AI in 2023 to significantly narrow as a result of EBCD revenue, and we project our AI segment to be
profitable in 2024.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fourth quarter of 2022, RadNet reported
Revenue from its Imaging Center reporting segment of $382.5 million and Adjusted EBITDA<SUP>(1)</SUP> of $61.6 million, which excludes
Revenue and Losses from the AI reporting segment. As compared with last year&rsquo;s fourth quarter, Revenue increased $50.3 million (or
15.1%) and Adjusted EBITDA<SUP>(1)</SUP> increased $9.6 million (or 18.4%), also excluding $2.9 million of Provider Relief Funding received
in the fourth quarter of 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Including our AI reporting segment, Revenue was
$383.9 million in the fourth quarter of 2022, an increase of 15.2% from $333.1 million in last year&rsquo;s fourth quarter. Including
the Adjusted EBITDA<SUP>(1) </SUP>losses of the AI reporting segment, Adjusted EBITDA<SUP>(1)</SUP> was $57.2 million in the fourth quarter
of 2022 and $51.7 million in the fourth quarter of 2021 (also excluding the Provider Relief Funding received in the fourth quarter of
2021).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fourth quarter of 2022, RadNet reported
a Net Loss of $934,000 as compared with a net loss of $3.8 million for the fourth quarter of 2021. Net Loss Per Share for the fourth quarter
of 2022 was $(0.02), compared with a Net Loss per share of $(0.07) in the fourth quarter of 2021, based upon a weighted average number
of diluted shares outstanding of 57.0 million shares in 2022 and 54.0 million shares in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were a number of unusual or one-time items
impacting the fourth quarter of 2022 including: $45,000 of non-cash gain from interest rate swaps (excluding the amortization of the accumulation
of the changes in fair value out of Other Comprehensive Income); $450,000 of severance paid in connection with headcount reductions related
to cost savings initiatives; $1.2 million expense related to leases for our de novo facilities under construction that have yet to open
their operations; $927,000 acquisition transaction costs primarily related to the purchase of Heart and Lung Imaging Limited; $47,000
of valuation adjustment for contingent consideration related to acquisitions; $731,000 expenses related to debt restructuring and loss
on extinguishment related to the refinancing of New Jersey Imaging Network&rsquo;s credit facilities; and $6.1 million of pre-tax losses
related to our AI reporting segment. Adjusting for the above items, Adjusted Earnings<SUP>(3)</SUP> from the Imaging Centers reporting
segment was $6.4 million and diluted Adjusted Earnings Per Share<SUP>(3)</SUP> was $0.11 during the fourth quarter of 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also, affecting Net Income in the fourth quarter
of 2022 were certain non-cash expenses and unusual items including: $4.7 million of non-cash employee stock compensation expense resulting
from the vesting of certain options and restricted stock; $1.6 million loss on the disposal of certain capital equipment; and $750,000
of non-cash amortization of deferred financing costs and loan discounts related to financing fees paid as part of our existing credit
facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fourth quarter of 2022, as compared with
the prior year&rsquo;s fourth quarter, MRI volume increased 11.9%, CT volume increased 11.8% and PET/CT volume increased 20.7%. Overall
volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 8.0% over the
prior year&rsquo;s fourth quarter. On a same-center basis, including only those centers which were part of RadNet for both the fourth
quarters of 2022 and 2021, MRI volume increased 7.5%, CT volume increased 6.0% and PET/CT volume increased 16.9%. Overall same-center
volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 3.6% over the
prior year&rsquo;s same quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Annual Report:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For full-year 2022, RadNet reported Revenue from
its Imaging Centers reporting segment of $1,426 million and Adjusted EBITDA<SUP>(1)</SUP> Excluding Losses from the AI reporting segment
of $209.0 million. Revenue increased $112.0 million (or 8.5%) and Adjusted EBITDA<SUP>(1)</SUP> decreased $2.9 million (or 1.4%), excluding
$9.1 million of Provider Relief Funding received in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Including our AI reporting segment Revenue of
$4.4 million, Revenue was $1,430 million for full-year 2022, an increase of 8.7% from $1,315 million in 2021. Including Adjusted EBITDA<SUP>(1)</SUP>
losses from the AI segment, Adjusted EBITDA<SUP>(1) </SUP>for 2022 was $192.5 million as compared with $209.8 million in 2021 (which includes
a one-time $7.7 million benefit from the employee retention credit and excludes $9.1 million of Provider Relief Funding received in 2021).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For 2022, RadNet reported Net Income of $10.7
million, a decrease of approximately $14.1 million over 2021. Per share diluted Net Income for the full year of 2022 was $0.17, compared
to a diluted Net Income per share of $0.46 in 2021 (based upon a weighted average number of diluted shares outstanding of 57.3 million
in 2022 and 53.4 million in 2021).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Affecting Net Income in 2022 were certain non-cash
expenses and unusual items including: $39.6 million of non-cash gain from interest rate swaps; $946,000 of severance paid in connection
with headcount reductions related to cost savings initiatives; $4.3 million expense related to leases for our de novo facilities under
construction that have yet to open their operations; $24.9 million of pre-tax losses related to our AI reporting segment; $23.8 million
of non-cash employee stock compensation expense resulting from the vesting of certain options and restricted stock; $731,000 expenses
related to debt restructuring and loss on extinguishment related to the refinancing of New Jersey Imaging Network&rsquo;s credit facilities;
$2.2 million in legal settlements; $2.5 million loss on the disposal of certain capital equipment; $8.1 million change in estimate related
to refund liability; and $2.7 million of non-cash amortization of deferred financing costs and loan discounts related to financing fees
paid as part of our existing credit facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Actual 2022 Results vs. 2022 Guidance:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following compares the Company&rsquo;s 2022
performance with previously announced revised guidance levels.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom">Original Guidance Range</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom">Revised Guidance Range After Q3 Results</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom">2022 Actual Results</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD STYLE="width: 34%"><FONT STYLE="font-size: 10pt">Revenue &ndash; Imaging Center Ops.</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">$1,350 - $1,400 million</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">$1,360 - $1,410 million</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">$1,426 million</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Adjusted EBITDA<SUP>(1)</SUP> Excluding Losses from AI Segment</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$205 - $215 million</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$203 - $208 million</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$209 million</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD><FONT STYLE="font-size: 10pt">Capital Expenditures<SUP>(a)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$85 - $90 million</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$100 - $105 million</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$109 million</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">Cash Paid for Interest<SUP>(c)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$27 - $32 million</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$35 - $40 million</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$39 million</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD><FONT STYLE="font-size: 10pt">Free Cash Flow <SUP>(b)(2)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$80 - $90 million</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$60 - $70 million</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$61 million</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">Net of proceeds from the sale of equipment, imaging centers and joint venture interests, and excludes
New Jersey Imaging Network capital expenditures (net of disposition proceeds) of $6.3 million.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Defined by the Company as Adjusted EBITDA</FONT><SUP>(1)</SUP> <FONT STYLE="font-size: 10pt">less
Capital Expenditures and Cash Paid for Interest. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">Excludes payments to and from counterparties of interest rate swaps.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger commented, &ldquo;Our strong operating
performance in the fourth quarter drove us to meet or exceed most all of our projected guidance ranges. Our 2022 results were above the
high end of our revised Revenue and Adjusted EBITDA<SUP>(1) </SUP>guidance ranges. Additionally, our Free Cash Flow<SUP>(2)</SUP> results
fell within our revised guidance range, despite our higher than originally projected capital expenditures as a result of the construction
of certain de novo locations. We are very pleased with these results in light of the difficult labor market we faced throughout most of
2022, impacting the availability and cost of staffing.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>2023 Fiscal Year Guidance</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For its 2023 fiscal year, RadNet announces its
guidance ranges as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><U>Imaging Center Segment</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 35%; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD><FONT STYLE="font-size: 10pt">Revenue</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1,525 million - $1,575 million</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">Adjusted EBITDA<SUP>(1)</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$220 million - $230 million</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD><FONT STYLE="font-size: 10pt">Capital Expenditures <SUP>(a)</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$105 million - $115 million</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">Cash Paid for Interest <SUP>(c)</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$35 million - $40 million</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD><FONT STYLE="font-size: 10pt">Free Cash Flow Generation <SUP>(b)(2)</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$70 million - $80 million</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><U>Artificial Intelligence Segment</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD><FONT STYLE="font-size: 10pt">Revenue</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$16 million - $18 million</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">Adjusted EBITDA<SUP>(1)</SUP> (Loss)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$(9) million - $(11) million</FONT></TD></TR>
  </TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">________________&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">Net of proceeds from the sale of equipment, imaging centers and joint venture interests, and excludes
New Jersey Imaging Network capital expenditures.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Defined by the Company as Adjusted EBITDA</FONT><SUP>(1)</SUP> <FONT STYLE="font-size: 10pt">from
Imaging Center Segment less Capital Expenditures and Cash Paid for Interest.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">Net of payments to and from counterparties on interest rate swaps.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger noted, &ldquo;We are anticipating strong
results in 2023, demonstrating improvement in all financial and operating metrics. We are projecting Revenue growth from imaging center
operations of between 7% and 10% and Adjusted EBITDA<SUP>(1)</SUP> growth from imaging center operations of between 5% and 10%. The anticipated
growth implicit in our guidance in 2023 is projected to result from same-center growth, the contribution of various de novo locations
opened in the second half of 2022 and scheduled to open throughout 2023, reimbursement increases from private and capitated payers, new
and expanded health system joint ventures and the further contribution from acquisitions completed at various times during 2022.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger continued, &ldquo;Our Adjusted EBITDA<SUP>(1)</SUP>
guidance for 2023 excludes anticipated Adjusted EBITDA<SUP>(1)</SUP> losses of approximately $10 million from our AI division (DeepHealth,
Aidence and Quantib). We estimate that these losses will be net of approximately $16 million to $18 million of anticipated Revenue from
both the Enhanced Breast Cancer Detection (EBCD) mammography program currently being implemented and additional growth from Aidence and
Quantib AI operations. We anticipate the AI operating segment to be profitable in 2024, and will continue to report the financial results
of our AI and imaging center operating segments separately each quarter throughout 2023, providing transparency for our stakeholders to
track our progress,&rdquo; concluded Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Conference Call for Today</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief Executive
Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call today, at 10:30 a.m. Eastern
Time. During the call, management will discuss the Company's 2022 fourth quarter and year-end results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Conference Call Details:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: Tuesday, February 28, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Time: 10:30 a.m. ET</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dial In-Number: 877-407-0789</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">International Dial-In Number: 201-689-8562</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">There will also be simultaneous and archived
webcasts available at </FONT><FONT STYLE="font-weight: normal">https://viavid.webcasts.com/starthere.jsp?ei=1598450&amp;tp_key=1aa3f92537</FONT>
<FONT STYLE="font-size: 10pt">or http://www.radnet.com under the &ldquo;About RadNet&rdquo; menu section and &ldquo;News &amp; Press Releases&rdquo;
sub-menu of the website. An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S.,
or 412-317-6671 for international callers, and using the passcode 13736399.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>About RadNet, Inc.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RadNet, Inc. is the leading national provider of freestanding, fixed-site
diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States based
on the number of locations and annual imaging revenue. RadNet has a network of 357 owned and/or operated outpatient imaging centers. RadNet's
markets include California, Maryland, Delaware, New Jersey, New York, Florida and Arizona. Together with affiliated radiologists, and
inclusive of full-time and per diem employees and technologists, RadNet has a total of approximately 9,000 employees. For more information,
visit http://www.radnet.com.</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>Forward Looking Statements</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">This press release contains &ldquo;forward-looking
statements&rdquo; within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking
statements are expressions of our current beliefs, expectations and assumptions regarding the future of our business, future plans and
strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can generally be identified
by words such as: &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;goal,&rdquo; &ldquo;seek,&rdquo; &ldquo;believe,&rdquo;
&ldquo;project,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;strategy,&rdquo; &ldquo;future,&rdquo; &ldquo;likely,&rdquo;
&ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;will&rdquo; and similar references to future periods. Forward-looking statements in this
press release include, among others, statements we make regarding response to and the expected future impacts of COVID-19, including statements
about our anticipated business results, balance sheet and liquidity and our future liquidity, burn rate and our continuing ability to
service or refinance our current indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">Forward-looking statements are neither historical
facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to uncertainties,
risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and
financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue
reliance on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to
differ materially from those indicated in the forward-looking statements include, among others, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the ongoing impact of the COVID-19 pandemic on
our business, suppliers, payors, customers, referral sources, partners, patients and employees, including (i) government&rsquo;s unprecedented
action regarding existing and potential restrictions and/or obligations related to citizen and business activity to contain the virus;
(ii) the consequences of an economic downturn resulting from the impacts of COVID-19 and the possibility of a global economic recession;
(iii) the impact of the volume of canceled or rescheduled procedures, whether as a result of government action or patient choice; (iv)
measures we are taking to respond to the COVID-19 pandemic, including changes to business practices; (v) the impact of government and
administrative regulation, guidance and appropriations; (vi) changes in our revenues due to declining patient procedure volumes, changes
in payor mix; (vii) potential increased expenses or workforce disruptions related to our employees that could lead to unavailability of
key personnel; (viii) workforce disruptions related to our key partners, suppliers, vendors and others we do business with; (ix) the impact
of return to work orders in certain states in which we operate; and (x) increased credit and collectability risks;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the availability and terms of capital to fund
our business;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our ability to service our indebtedness, make
principal and interest payments as those payments become due and remain in compliance with applicable debt covenants, in addition to our
ability to refinance such indebtedness on acceptable terms;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in general economic conditions nationally
and regionally in the markets in which we operate, including their effects on the cost and availability of labor;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the availability and terms of capital to fund
the expansion of our business and improvements to our existing facilities;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our ability to maintain our current credit rating
and the impact on our funding costs and competitive position if we do not do so;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">volatility in interest and exchange rates, or
credit markets;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the adequacy of our cash flow and earnings to
fund our current and future operations;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in service mix, revenue mix and procedure
volumes; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">delays in receiving payments for services provided;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">increased bankruptcies among our partner physicians
or joint venture partners;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the impact of the political environment and related
developments on the current healthcare marketplace and on our business, including with respect to the future of the Affordable Care Act;
</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the extent to which the ongoing implementation
of healthcare reform, or changes in or new legislation, regulations or guidance, enforcement thereof by federal and state regulators or
related litigation result in a reduction in coverage or reimbursement rates for our services, or other material impacts to our business;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">closures or slowdowns and changes in labor costs
and labor difficulties, including stoppages affecting either our operations or our suppliers' abilities to deliver supplies needed in
our facilities;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the occurrence of hostilities, political instability
or catastrophic events; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the emergence or reemergence of and effects related
to future pandemics, epidemics and infectious diseases; and </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">noncompliance by us with any privacy or security
laws or any cybersecurity incident or other security breach by us or a third party involving the misappropriation, loss or other unauthorized
use or disclosure of confidential information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any forward-looking statement contained in this
current report is based on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation
to publicly update any forward-looking statement, whether written or oral, that we may make from time to time, whether as a result of
changed circumstances, new information, future developments or otherwise, except as required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Regulation G: GAAP and Non-GAAP Financial
Information</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This release contains certain financial information
not reported in accordance with GAAP. The Company uses both GAAP and non-GAAP metrics to measure its financial results. The Company believes
that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in measuring its cash-based performance. The Company believes
this information is useful to investors and other interested parties because it removes unusual and nonrecurring charges that occur in
the affected period and provides a basis for measuring the Company's financial condition against other quarters. Such information should
not be considered as a substitute for any measures calculated in accordance with GAAP, and may not be comparable to other similarly titled
measures of other companies. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial
information prepared in accordance with GAAP. Reconciliation of this information to the most comparable GAAP measures is included in this
release in the tables which follow.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>CONTACTS: </I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>RadNet, Inc.</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mark Stolper, 310-445-2800</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Executive Vice President and Chief Financial
Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 406.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONSOLIDATED BALANCE SHEETS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">As of December 31,</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center">ASSETS</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">CURRENT ASSETS</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 66%; font-size: 10pt; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">127,834</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">134,606</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Accounts receivable, net</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">166,357</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">135,062</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Due from affiliates</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">18,971</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,384</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">54,022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">49,212</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Total current assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">367,184</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">324,264</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Property and equipment, net</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">565,961</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">484,247</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Operating lease right-of-use assets</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">603,524</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">584,291</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Total property, equipment and right-of-use assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,169,485</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,068,538</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">OTHER ASSETS</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Goodwill</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">677,665</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">513,820</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Other intangible assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">106,228</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">56,603</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Deferred financing costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,280</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,135</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Investment in joint ventures</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">57,893</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">42,229</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Deferred tax assets, net of current portion</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">14,853</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Deposits and other</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">53,172</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">36,032</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total assets</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,433,907</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,058,474</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center">LIABILITIES AND EQUITY</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">CURRENT LIABILITIES</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Accounts payable, accrued expenses and other</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">369,595</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">263,937</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Due to affiliates</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">23,100</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">23,530</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Deferred revenue related to software sales</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,021</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10,701</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Current portion of operating lease</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">57,607</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">65,452</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Current portion of notes payable and long term debt</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">12,400</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">11,164</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Total current liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">466,723</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">374,784</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">LONG-TERM LIABILITIES</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Operating lease, net of current portion</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">604,117</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">577,675</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Notes payable, net of current portion</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">839,344</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">743,498</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Deferred tax liability</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">9,256</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other non-current liabilities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">23,015</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">16,360</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Total liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,942,455</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,712,317</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold">EQUITY</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">RadNet, Inc. stockholders' equity:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Common stock - $.0001 par value, 200,000,000 shares authorized; 57,723,125 and 53,458,227 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Additional paid-in-capital</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">436,288</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">342,592</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Accumulated other comprehensive (loss) income</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(20,677</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(20,421</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(82,622</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(93,272</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Total RadNet, Inc.'s stockholders' equity</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">332,995</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">228,904</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Noncontrolling interests</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">158,457</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">117,253</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Total equity</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">491,452</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">346,157</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total liabilities and equity</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,433,907</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,058,474</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONSOLIDATED STATEMENTS OF OPERATIONS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Years Ended December 31,</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold">REVENUE</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 55%; font-size: 10pt; text-align: left">Service fee revenue</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">1,278,016</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">1,166,743</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">931,722</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Revenue under capitation arrangements</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">152,045</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">148,334</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">140,118</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Total revenue</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,430,061</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,315,077</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,071,840</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Provider relief funding</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">9,110</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">26,264</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">OPERATING EXPENSES</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Cost of operations, excluding depreciation and amortization</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,264,346</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,123,274</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">965,902</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Lease abandonment charges</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19,675</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Depreciation and amortization</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">115,877</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">96,694</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">86,795</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Loss on sale and disposal of equipment and other</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,529</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,246</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,200</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Loss on impairment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,170</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Severance costs</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">946</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">744</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4,353</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,383,698</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,241,633</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,062,420</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">INCOME FROM OPERATIONS</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">46,363</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">82,554</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">35,684</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">OTHER INCOME AND EXPENSES</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Interest expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,841</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">48,830</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,882</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Equity in earnings of joint ventures</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(10,390</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(10,967</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(7,945</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Non-cash change in fair value of interest rate hedge</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(39,621</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(21,670</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,528</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Loss (gain) on extinguishment of debt and related expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">731</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,044</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(4,047</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,833</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,438</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">120</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Total other expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,394</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">23,675</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">36,538</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">INCOME (LOSS) BEFORE INCOME TAXES</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">42,969</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">58,879</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(854</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Provision for income taxes</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(9,361</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(14,560</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(895</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">NET INCOME (LOSS)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">33,608</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">44,319</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,749</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Net income attributable to noncontrolling interests</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">22,958</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">19,592</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">13,091</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt">NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">10,650</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">24,727</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(14,840</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.19</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.47</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.29</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.17</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.46</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.29</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt">Basic</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">56,293,336</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">52,496,679</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">50,891,791</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt">Diluted</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">57,320,870</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">53,421,033</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">50,891,791</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONSOLIDATED STATEMENTS OF CASH FLOWS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Years Ended December 31,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 55%; font-size: 10pt; text-align: left">Net income (loss)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">33,608</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">44,319</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">(1,749</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Adjustments to reconcile net income&nbsp;to net cash provided by operating activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Depreciation and amortization</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">115,877</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">96,694</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">86,795</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Amortization of operating right-of-use assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">68,847</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">73,967</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">67,915</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Lease abandonment charges</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19,675</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Equity in earnings of joint ventures</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(10,390</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(10,967</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(7,945</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Distributions from joint ventures</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,438</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,707</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">9,522</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Amortization and write off of deferred financing costs and loan discount</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,693</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,254</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,413</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Loss on sale and disposal of equipment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,529</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,246</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,200</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Loss (gain) on extinguishment of debt</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,496</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(4,047</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Loss on impairment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,170</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Amortization of cash flow hedge</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,687</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,695</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,448</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Non-cash change in fair value of interest rate hedge</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(39,621</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-21,670</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,528</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Stock-based compensation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">23,770</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,203</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12,405</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Other non cash item in other expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">242</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Change in value of contingent consideration</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(325</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; text-indent: -5pt">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Accounts receivable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(30,078</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(5,890</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,206</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Other current assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(3,327</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(15,777</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,588</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Other assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(12,166</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">662</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(5,425</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Deferred taxes</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">13,356</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19,834</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(611</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Operating lease liability</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(68,943</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(72,553</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(53,906</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Deferred revenue</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(7,316</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(28,319</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">37,941</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Accounts payable, accrued expenses and other</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">49,778</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">9,915</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">45,069</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 30pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Net cash provided by operating activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">146,417</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">149,491</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">233,759</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Purchase of imaging facilities and other operations</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(129,961</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(77,691</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(31,265</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Purchase of property and equipment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(119,451</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(137,874</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(94,172</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Purchase of intangible assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(5,130</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Proceeds from sale of equipment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,904</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">625</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">828</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Equity contributions in existing and purchase of interest in joint ventures</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,441</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,441</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,635</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 30pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(246,949</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(221,511</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(126,244</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Payments on senior notes</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(53,750</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(619,529</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(43,296</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Principal payments on notes and leases payable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(3,302</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(3,562</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Additional deferred finance costs on revolving loan amendment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(938</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(741</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Proceeds from debt issuance, net of issuance costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">147,996</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">717,307</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Proceeds from Payment Protection Program</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,023</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Distributions paid to noncontrolling interests</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(893</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,426</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,985</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Proceeds from sale of noncontrolling interest</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">13,073</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Proceeds from revolving credit facility</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">128,300</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">250,900</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Payments on revolving credit facility</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(128,300</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(250,900</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Proceeds from issuance of common stock upon exercise of options</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">294</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">488</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 30pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Net cash provided by (used in)&nbsp;&nbsp;financing activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">93,647</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">104,673</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(45,561</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">EFFECT OF EXCHANGE RATE CHANGES ON CASH</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">113</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(65</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(101</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(6,772</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">32,588</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">61,853</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">CASH AND CASH EQUIVALENTS, beginning of period</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">134,606</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">102,018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">40,165</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">CASH AND CASH EQUIVALENTS, end of period</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">127,834</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">134,606</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">102,018</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Cash paid during the period for interest</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">39,151</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">29,042</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">39,521</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Cash paid during the period for income taxes</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">587</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">1,950</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">5,069</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months Ended December 31</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">REVENUE</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 66%; font-size: 10pt; text-align: left">Service fee revenue</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">346,197</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">296,264</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Revenue under capitation arrangements</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">37,678</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">36,885</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Total revenue</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">383,875</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">333,150</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Provider relief funding</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,819</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">OPERATING EXPENSES</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Cost of operations, excluding depreciation and amortization</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">329,589</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">284,667</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Lease abandonment charges</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19,675</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Depreciation and amortization</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">30,668</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,421</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Loss on sale and disposal of equipment and other</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,567</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,524</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Severance costs</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">450</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">29</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">362,274</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">331,316</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">INCOME FROM OPERATIONS</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">21,601</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,652</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">OTHER INCOME AND EXPENSES</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Interest expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15,442</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">11,801</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Equity in earnings of joint ventures</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,040</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,707</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Non-cash change in fair value of interest rate swaps</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(45</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(7,520</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Debt restructuring and extinguishment expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">731</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other expenses (income)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">270</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(261</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Total other expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">14,358</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,312</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">INCOME BEFORE INCOME TAXES</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7,243</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,340</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Provision for income taxes</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(2,274</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(2,027</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">NET INCOME</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,969</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,313</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Net income attributable to noncontrolling interests</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">5,903</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">5,137</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">NET (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(934</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(3,823</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt">BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.02</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.07</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt">DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.02</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.07</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Basic</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">57,040,622</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">53,046,706</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Diluted</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">57,040,622</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">53,964,751</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RECONCILIATION OF GAAP NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON SHAREHOLDERS TO ADJUSTED EBITDA</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months Ended December 31,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Twelve Months Ended December 31</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; width: 40%; font-size: 10pt; text-align: left; text-indent: -5pt">Net (loss) income attributable to RadNet, Inc. common stockholders</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">(934</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">(3,823</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">10,650</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">24,727</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Income taxes</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,274</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,027</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">9,361</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">14,560</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Interest expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15,442</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">11,801</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,841</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">48,830</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Severance costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">450</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">29</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">946</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">744</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Depreciation and amortization</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">30,668</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,421</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">115,877</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">96,694</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Non-cash employee stock-based compensation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,658</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,637</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">23,770</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,203</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Loss on sale and disposal of equipment and other</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,567</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,524</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,529</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,246</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Debt restructuring and loss on extinguishment expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">731</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">731</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,044</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Non-cash change in fair value of interest rate hedge</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(45</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(7,520</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(39,621</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(21,670</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Other adjustment to joint venture investment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(565</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Other expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">270</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(261</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,833</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,438</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Legal settlements</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">831</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,197</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">831</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Change in estimate related refund liability</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8,089</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Lease Abandonment Charges</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19,675</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19,675</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Non operational rent expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,177</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,297</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Acquisition transaction costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">927</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,171</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">927</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,171</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Valuation adjustment for contingent consideration</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">47</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">47</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt">Adjusted EBITDA Including Losses from AI Segment and Provider Relief funding</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">57,232</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">54,512</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">192,474</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">218,928</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Provider relief funding</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,819</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(9,110</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt">Adjusted EBITDA Including Losses from AI Segment and excluding benefit from Provider Relief Funding</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">57,232</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">51,693</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">192,474</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">209,818</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Adjusted EBITDA losses from AI Segment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,321</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">304</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16,575</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,121</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt">Adjusted EBITDA excluding Losses from AI Segment and Provider relief funding</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">61,553</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">51,997</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">209,049</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">211,939</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">SCHEDULE OF ADJUSTED EARNINGS AND EARNINGS PER SHARE <FONT STYLE="font: normal 700 10pt Times New Roman, Times, Serif"><SUP>(3)</SUP></FONT></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE DATA)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended<BR>
December31,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 66%; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">COMMON STOCKHOLDERS</TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(934</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(3,823</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Add severance costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">450</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">29</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Add loss on lease abandonment/impairment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19,675</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Add legal settlement and related expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">831</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Add debt restructuring and loss on extinguishment expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">731</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Add transaction costs Aidence Holdings B.V. &amp; Quantib B.V.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,171</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Add non-operational rent expenses (i)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,177</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Add AI Segment losses (iv)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,060</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">652</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Add acquisition transaction costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">927</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Add valuation adjustment for contingent consideration</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">47</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Subtract Provider Relief Funding</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,819</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Subtract non-cash gain on swap valuation (ii)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(45</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(7,520</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Total adjustments - loss (gain)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">9,347</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12,019</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Subtract tax impact of Adjustments (iii)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,031</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,972</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">TOTAL ADJUSTMENT TO NET INCOME ATTRIBUTABLE</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 10pt">TO RADNET, INC. COMMON SHAREHOLDERS</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">7,316</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">9,047</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt">ADJUSTED NET INCOME ATTRIBUTABLE TO RADNET,
    INC. COMMON STOCKHOLDERS</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">6,382</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">5,224</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 10pt">Diluted</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">58,164,555</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">53,964,751</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">ADJUSTED DILUTED NET INCOME PER SHARE</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.11</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.10</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">____________________</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 2pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 20pt; text-align: left">(i)</TD><TD STYLE="text-align: justify">Represents rent expense associated with de novo sites under construction
prior to them becoming operational.</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 20pt; text-align: left">(ii)</TD><TD STYLE="text-align: justify">Impact from the change in fair value of the swaps during the quarter.
Excludes the amortization of the accumulation of the changes in fair value out of Other Comprehensive Income that existed prior to the
hedges becoming ineffective.</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 20pt; text-align: left">(iii)</TD><TD STYLE="text-align: justify">Tax effected using 21.73% and 24.73% blended federal and state
effective tax rate for 2022 and 2021, respectively.</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 20pt; text-align: left">(iv)</TD><TD STYLE="text-align: justify">Represents pre-tax net income losses before income taxes from
Artificial Intelligence reporting segment.</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PAYOR CLASS BREAKDOWN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 55%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 40%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; background-color: white; width: 13%">Fourth Quarter</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 0.5pt solid; text-align: center; background-color: white">2022</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="background-color: white">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Commercial Insurance</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">57.7%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Medicare</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">22.0%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Capitation</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">9.8%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Medicaid</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">2.5%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Workers Compensation/Personal Injury</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">3.2%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Other</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 0.5pt solid; text-align: right">4.7%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Total</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">100.0%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-indent: 20pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RADNET PAYMENTS BY MODALITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">Fourth Quarter</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">Full Year</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">Full Year</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">Full Year</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 40%; font-size: 10pt">MRI</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">36.4%</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">36.8%</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">36.0%</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">35.4%</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">CT</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17.2%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17.5%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17.2%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17.6%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">PET/CT</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5.8%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5.8%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5.5%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.0%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">X-ray</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.4%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.7%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3.9%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7.3%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">Ultrasound</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12.8%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12.6%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12.7%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12.3%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Mammography</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16.0%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15.3%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16.1%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15.7%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Nuclear Medicine</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0.8%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0.9%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.0%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.0%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">Other</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4.6%</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4.5%</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4.6%</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4.7%</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">100.0%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">100.0%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">100.0%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">100.0%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 321.1pt"><U><BR STYLE="clear: both">
Footnotes</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>&nbsp;</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(1)</SUP> The Company defines Adjusted EBITDA
as earnings before interest, taxes, depreciation and amortization, each from continuing operations and excludes losses or gains on the
disposal of equipment, other income or loss, loss on debt extinguishments, bargain purchase gains and non-cash equity compensation. Adjusted
EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries,
and is adjusted for non-cash and extraordinary events which took place during the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted EBITDA is reconciled to its nearest comparable
GAAP financial measure. Adjusted EBITDA is a non-GAAP financial measure used as analytical indicator by RadNet management and the healthcare
industry to assess business performance, and is a measure of leverage capacity and ability to service debt. Adjusted EBITDA should not
be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation
or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data
presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a
measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented,
may not be comparable to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(2)</SUP> As noted above, the Company defines
Free Cash Flow as Adjusted EBITDA less total Capital Expenditures (whether completed with cash or financed) and Cash Interest paid. Free
Cash Flow is a non-GAAP financial measure. The Company uses Free Cash Flow because the Company believes it provides useful information
for investors and management because it measures our capacity to generate cash from our operating activities. Free Cash Flow does not
represent total cash flow since it does not include the cash flows generated by or used in financing activities. In addition, our definition
of Free Cash Flow may differ from definitions used by other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Free Cash Flow should not be considered a measure
of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives
to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the
consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a measurement determined
in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable
to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(3)</SUP> The Company defines Adjusted Earnings
Per Share as net income or loss attributable to RadNet, Inc. common stockholders and excludes losses or gains on the disposal of equipment,
loss on debt extinguishments, bargain purchase gains, severance costs, loss on impairment, loss or gain on swap valuation, gain on extinguishment
of debt, unusual or non-recurring entries that impact the Company&rsquo;s tax provision, pre-tax loss or gain from AI segment and any
other non-recurring or unusual transactions recorded during the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted Earnings Per Share is reconciled to its
nearest comparable GAAP financial measure. Adjusted Earnings Per Share is a non-GAAP financial measure used as analytical indicator by
RadNet management and the healthcare industry to assess business performance. Adjusted Earnings Per Share should not be considered a measure
of financial performance under GAAP, and the items excluded from Adjusted Earnings Per Share should not be considered in isolation or
as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data
presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted Earnings Per Share
is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as
presented, may not be comparable to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>radnet_ex9902.htm
<DESCRIPTION>TRANSCRIPT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 99.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_057.jpg" ALT=""><BR STYLE="clear: both">
&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_058.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Blue"><B>C O R P O R A T
E&nbsp;&nbsp;&nbsp;&nbsp; P A R T I C I P A N T S</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper, </B><I>Executive Vice President
and Chief Financial Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger, MD, </B><I>President and
Chief Executive Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Blue"><B>C O N F E R E N
C E &nbsp;&nbsp;&nbsp;C A L L &nbsp;&nbsp;&nbsp;P A R T I C I P A N T S</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut, </B><I>Jefferies</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>John Ransom, </B><I>Raymond James</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal, </B><I>Sidoti &amp; Company</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Blue"><B>P R E S E N T A
T I O N</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Greetings, and welcome to the RadNet, Inc. Fourth
Quarter 2022 Financial Results Call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, all participants are in a listen-only
mode. A brief question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is now my pleasure to introduce your host,
Mark Stolper, Executive Vice President and Chief Financial Officer. Thank you. Mark, you may begin.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. Good morning, and thank you for joining
Dr. Howard Berger and me today to discuss RadNet&rsquo;s fourth quarter and full year 2022 results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before we begin today, we&rsquo;d like to remind
everyone of the Safe Harbor statement under the Private Securities Litigation Reform Act of 1995. This presentation contains forward-looking
statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning anticipated
future financial and operating performance, RadNet&rsquo;s ability to continue to grow the business by generating patient referrals and
contracts with radiology practices, recruiting and retaining technologists, receiving third-party reimbursement for diagnostic imaging
services, successfully integrating acquired operations, generating revenue and Adjusted EBITDA for the acquired operations as estimated,
among others, are forward-looking statements within the meaning of the Safe Harbor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Forward-looking statements are based on Management&rsquo;s
current preliminary expectations and are subject to risks and uncertainties which may cause RadNet&rsquo;s actual results to differ materially
from the statements contained herein. These risks and uncertainties include those risks set forth in RadNet&rsquo;s reports filed with
the SEC from time to time, including RadNet&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2022, to be filed shortly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">ViaVid has made
considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting
of the substance of the conference call. This transcript is being made available for information purposes only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">1-888-562-0262 1-604-929-1352
www.viavid.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<IMG SRC="image_058.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Undue reliance should not be placed on forward-looking
statements, especially guidance on future financial performance, which speaks only as of the date it is made. RadNet undertakes no obligation
to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or
to reflect the occurrence of unanticipated events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that, I&rsquo;d like to turn the call over
to Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mark. Good morning, everyone, and thank
you for joining us today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On today&rsquo;s call, Mark and I plan to provide
you with highlights from our fourth quarter and full year 2022 results, give you more insight into factors which affected this performance,
and discuss our future strategy. After our prepared remarks, we will open the call to your questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;d like to thank all of you for your interest
in our Company and for dedicating a portion of your day to participate in our conference call this morning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Let&rsquo;s begin.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;m extremely pleased with our strong performance
in the fourth quarter. We grew our revenue by over 15% and our Adjusted EBITDA by over 13% from last year&rsquo;s fourth quarter, resulting
in quarterly records for both revenue and Adjusted EBITDA. The strong performance was the result of a combination of growing procedural
demand for our services and improving conditions in our labor markets. Demand for our services remains robust in virtually all of the
markets, as outpatient imaging continues to be shifted from more expensive hospital settings towards more cost-efficient ambulatory sites,
like the ones RadNet operates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Contributing to our record Adjusted EBITDA performance
was also an improving labor market. During the fourth quarter, and thus far in 2023, we have been more successful in filling open positions
and retaining existing staff. Furthermore, COVID has had less of an impact on our workforce with respect to taking sick days, enabling
us to staff our centers more effectively to meet heavy procedural demand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consistent with our efforts throughout the pandemic,
during the fourth quarter, we continued to focus on strengthening our balance sheet by managing our liquidity and financial leverage.
At the year end 2022, we had a cash balance of over $127 million and a net leverage ratio of under 3.5 times Adjusted EBITDA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our days sales outstanding, DSOs, at December
31, 2022 was under 39.0 days, close to our historic low. The improvement in revenue cycle operations and collections has materially contributed
to our ability to manage the challenges presented by COVID-19 and the difficult labor market, while affording us the ability to make important
investments in our future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These investments in our future have been focused
in four principal areas that we believe are key elements to our near-term growth:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">First, as we discussed last year, we have been
in development of over a dozen de novo facilities, most of which will open for operations in 2023. These facilities are located in markets
where we have patient backlogs, require additional capacity, or in locations where we currently lack access points to service identified
patient populations. The largest of these de novo centers, in the downtown area of Phoenix, is now operational and has begun to service
patient volume.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_058.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A second area of investment and focus will be
expanding our joint venture initiatives. We currently have 24 health system joint ventures, representing one-third, or 119 centers, of
our 357 centers. We continue to believe that we could have more than half of our centers in health system partnerships within three years.
Forward-thinking and entrepreneurial health systems are increasingly seeking a long-term, viable strategy for outpatient diagnostic imaging
and RadNet represents an attractive strategic direction for these organizations. During 2022, as an example, we established a new joint
venture in Frederick, Maryland, and expanded several others with our partners, including Cedars-Sinai medical center in the Los Angeles
area and Dignity Health CommonSpirit in Arizona. As we look ahead to this year, we anticipate the expansion of several health system relationships
and the establishment of new joint venture relationships. As payors, patients and referring physicians continue to shift outpatient volumes
from hospitals into ambulatory outpatient centers, we are receiving increasing interest in the partnership models we can offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Third, tuck-in acquisitions will remain an important
part of our growth strategy and investment. Our industry remains fragmented and consolidation will continue as pressure mounts on smaller
operators. Motivated sellers are appearing as a result of the rising cost of capital, increased interest rates, reimbursement pressure
from Medicare and private payors, and the necessity of scale to drive efficiencies and profitability. Becoming part of RadNet for these
smaller operators represents a way to create more security for their future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2022, we completed several tuck-in acquisitions.
The largest tuck-in acquisition we completed during 2022 was the fourth quarter acquisition of Montclair Radiology Associates by our New
Jersey Imaging Network joint venture with the RWJBarnabas hospital system. Montclair was an entrenched and well-respected operator in
Northern New Jersey, with six high-performing imaging centers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also notable, during the fourth quarter of 2022,
we acquired a controlling interest in Heart &amp; Lung Health, HLH, a London-based teleradiology network focused on lung cancer screening.
HLH has established itself as the leading provider of lung cancer screening services to the U.K. National Health Service&rsquo;s Targeted
Lung Health Checks Program, which mandates the combined use of artificial intelligence and expert radiologist interpretation for widespread
population health lung cancer screening. HLH utilizes software from RadNet&rsquo;s AI subsidiary Aidence and is anticipated that the program
could drive over 1 million lung scans in England alone when the program becomes fully implemented, which is targeted by the end of 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Finally, we continue to invest and pursue growth
opportunities in artificial intelligence. In November, we initiated a pilot of a new Enhanced Breast Cancer Detection service in Delaware,
called EBCD. The offering works in concert with a patient&rsquo;s annual breast screening regimen. For an additional fee, patients can
elect to enroll in a suite of premium mammography-related services, including the use of DeepHealth Saige-DX AI, personalized lifetime
risk assessment and additional AI-driven review for certain exams, and access to a dedicated 1-800 support line. Upon the successful completion
of the pilot, we began to implement a rollout of EBCD to our other East Coast markets during the fourth quarter, and we expect that EBCD
will be available in all of the RadNet&rsquo;s mammography centers by the end of this summer. Currently, we perform about 1.4 million
screening mammography exams annually.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">AI will continue to be an important growth driver
for our future. When Mark reviews our 2023 guidance, he will note that we anticipate to narrow our losses from AI in 2023, as a result
of both expected revenue from EBCD and growth from the sale and licensing of Quantib and Aidence products. We further expect that our
AI segment will turn a profit in 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_058.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I&rsquo;d like to turn the call
back over to Mark to discuss some of the highlights of our fourth quarter and full year 2022 performance, as well as discuss in detail
our guidance levels for 2023. When he is finished, I will make some closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Howard.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;m now going to briefly review our fourth
quarter and full year 2022 performance and attempt to highlight what I believe to be some material items. I will also give some further
explanation of certain items in our financial statements, as well as provide some insights into some of the metrics that drove our fourth
quarter and full year 2022 performance. I will also provide 2023 financial guidance levels, which were released in this morning&rsquo;s
financial results press release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In my discussion, I will use the term Adjusted
EBITDA, which is a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and
amortization, and excludes losses or gains on the disposal of equipment, other income or loss, loss on debt extinguishments and non-cash
equity compensation. Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling
interest in subsidiaries, and is adjusted for non-cash or extraordinary and one-time events taking place during the period. A full quantitative
reconciliation of Adjusted EBITDA to net income or loss attributable to RadNet, Inc. common shareholders is included in our earnings release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that said, I&rsquo;d now like to review our
fourth quarter and full year 2022 results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fourth quarter of 2022, RadNet reported
revenue from its imaging center reporting segment of $382.5 million and Adjusted EBITDA of $61.6 million, which excludes revenue and losses
from the AI segment. As compared with last year&rsquo;s fourth quarter, revenue increased $50.3 million, or 15.1%, and Adjusted EBITDA
increased $9.6 million, or 18.4%, also excluding $2.9 million of Provider Relieve Funding received in the fourth quarter of 2021. Including
our AI reporting segment, revenue was $383.9 million in the fourth quarter of 2022, an increase of 15.2%, from $333.1 million in last
year&rsquo;s fourth quarter. Including the Adjusted EBITDA losses of the AI reporting segment, Adjusted EBITDA was $57.2 million in the
fourth quarter of 2022, and $51.7 million in the fourth quarter of 2021, also excluding the Provider Relieve Funding received in the fourth
quarter of 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fourth quarter of 2022, as compared with
the prior year&rsquo;s fourth quarter, MRI volume increased 11.9%, CT volume increased 11.8%, and PET CT volume increased 20.7%. Overall
volume, taking into account routine imaging exams inclusive of X-ray, ultrasound, mammography and all other exams, increased 8% over the
prior year&rsquo;s fourth quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the fourth quarter of 2022, we performed 2,376,995
total procedures. The procedures were consistent with our multi-modality approach, whereby 75.6% of all the work we did by volume was
from routine imaging. Our procedures in the fourth quarter of 2022 were as follows: 352,009 MRIs, as compared with 314,682 MRIs in the
fourth quarter of 2021; 213,716 CTs, as compared with 191,180 CTs in the fourth quarter of 2021; 13,359 PET CTs, as compared with 11,066
PET CTs in the fourth quarter of 2021; and 1,797,911 routine imaging exams, compared with 1,684,992 of all these exams in the fourth quarter
of 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On a same-center basis, including only those centers
which were part of RadNet for both the fourth quarters of 2022 and 2021, MRI volume increased 7.5%, CT volume increased 6%, and PET CT
volume increased 16.9%. Overall same-center volume, taking into account all routine imaging exams, increased 3.6% over the prior year
same quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<IMG SRC="image_058.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fourth quarter of 2022, RadNet reported
a net loss of $934,000, as compared with a net loss of $3.8 million for the fourth quarter of 2021. Net loss per share for the fourth
quarter of 2022 was negative $0.02, compared with a net loss per share of negative $0.07 in the fourth quarter of 2021, based upon a weighted
average number of diluted shares outstanding of 57 million shares in 2022, and 54 million shares in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were a number of unusual or one-time items
impacting the fourth quarter of 2022, including the following: $45,000 of non-cash gain from interest rate swaps, which excludes the amortization
of the accumulation of the changes in fair value out of other comprehensive income; $450,000 of severance paid in connection with headcount
reductions related to cost savings initiatives; a $1.2 million expense related to leases of our de novo facilities under construction
that have yet to be opened for operation; a $927,000 acquisition transaction cost, primarily related to the purchase of Heart &amp; Lung
Imaging Limited; $47,000 of valuation adjustment for contingent consideration related to acquisitions; $731,000 expenses related to debt
structuring and loss on extinguishment related to the refinancing of New Jersey Imaging Network&rsquo;s credit facilities completed in
October; and $6.1 million of pre-tax losses related to our AI reporting segment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusting for the above items, adjusted earnings
from the imaging centers reporting segment was $6.4 million and diluted adjusted earnings per share was $0.11 during the fourth quarter
of 2022. This compares with adjusted earnings per share of $0.10 during the fourth quarter of 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also affecting net income in the fourth quarter
of 2022 were certain non-cash and unusual items, including the following: $4.7 million of non-cash employee stock compensation expense
resulting from the vesting of certain options and restricted stock; a $1.6 million loss on the disposal of certain capital equipment;
and $750,000 of non-cash amortization of deferred financing costs and loan discounts related to financing fees paid as part of our existing
credit facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With regards to some specific income statement
accounts, overall GAAP interest expense for the fourth quarter of 2022 was $15.4 million. This compares with GAAP interest expense in
the fourth quarter of 2021 of $11.8 million. Cash paid for interest during the period, which excludes non-cash deferred financing expense,
accrued interest and payments to and from swap counterparties, was $8.9 million, as compared with $7.6 million in the fourth quarter of
last year. The higher interest expense and cash paid for interest in this year&rsquo;s fourth quarter was a function of additional debt
on our balance sheet resulting from the $150 million New Jersey Imaging Network refinancing transaction completed on October 7 of 2022,
as well as higher interest rates since last year&rsquo;s fourth quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For full year 2022, RadNet reported revenue from
its imaging centers reporting segment of $1.426 billion and Adjusted EBITDA, excluding losses from AI reporting segment, of $209 million.
Revenue increased $112 million, or 8.5%, and Adjusted EBITDA decreased $2.9 million, or 1.4%, excluding $9.1 million of Provider Relieve
Funding received in 2021. Including our AI reporting segment revenue of $4.4 million, revenue was $1.430 billion for full year 2022, an
increase of 8.7% from $1.350 billion in 2021. Including Adjusted EBITDA losses from the AI segment, Adjusted EBITDA for 2022 was $192.5
million, as compared with $209.8 million in 2021, which includes a one-time $7.7 million benefit from the employee retention credit and
excludes $9.1 million of Provider Relieve Funding, both received in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2022, as compared
to 2021, MRI volume increased 10.7%, CT volume increased 9.6%, and PET CT volume increased 12.3%. Overall volume, taking into account
all routine imaging exams, increased 6.7% for the 12 months of 2022, over 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_058.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2022, we performed 9,175,804 total procedures.
The procedures were consistent with our multi-modality approach, whereby 75.5% of all the work we did by volume was from routine imaging.
Our procedures in 2022 were as follows: 1,346,303 MRIs, as compared with 1,232,427 MRIs in 2021; 828,952 CTs, as compared with 756,509
CTs in 2021; 50,684 PET CTs, as compared with 45,124 PET CTs in 2021; and 6,931,865 routine imaging exams, as compared with 6,564,533
of all these exams in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For 2022, RadNet reported net income of $10.7
million, a decrease of approximately $14.1 million over 2021. Per share diluted net income for the full year of 2022 was $0.17 per share,
compared to a diluted net income per share of $0.46 in 2021. This is based upon a weighted average number of diluted shares outstanding
of 57.3 million shares in 2022, and 53.4 million in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Affecting net income in 2022 were certain non-cash
expenses and unusual items, including the following: $39.6 million of non-cash gain from interest rate swaps; $946,000 of severance paid
in connection with headcount reductions related to cost savings initiatives; a $4.3 million expense related to leases for our de novo
facilities under construction that have yet to open their operations; $24.9 million of pre-tax losses related to our AI reporting segment;
$23.8 million of non-cash employee stock compensation expense resulting from the vesting of certain options and restricted stock; $731,000
expenses related to debt restructuring and loss on extinguishment related to the refinancing of our New Jersey Imaging Network&rsquo;s
credit facilities; $2.2 million in legal settlements; a $2.5 million loss on the disposal of certain capital equipment; an $8.1 million
charge in estimate related to a refund liability; and $2.7 million of non-cash amortization of deferred financing costs and loan discounts
related to financing fees paid as part of our existing credit facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With regards to some specific income statement
accounts, overall GAAP interest expense in 2022 was $50.8 million. Adjusting for the impacts from items, such as amortization of financing
fees, accrued interest and payments to swap counterparties, cash interest expense was $39.2 million in 2022. This compares with GAAP interest
expense in 2021 of $48.8 million and cash paid for interest of $29 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With regards to our balance sheet, as of December
31, 2022, unadjusted for bond and term loan discounts, we had $735 million of net debt, which is our total debt at par value less our
cash balance. Note that this debt balance includes New Jersey Imaging Network&rsquo;s debt of $150 million, for which RadNet is neither
a borrower nor guarantor. This compares with $633.3 million of net debt at December 31, 2021. As of year end 2022, we were undrawn on
our $195 million revolving line of credit and had a cash balance of $127.8 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At December 31, 2022, our accounts receivable
balance was $166.4 million, an increase of $31.3 million from year end 2021. Our DSO was 38.8 days at December 31,2022, which continues
to be near our all-time low.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Throughout 2022, we had total capital expenditures,
net of asset dispositions and the sale of imaging center assets and joint venture interest, of $109.3 million. This amount excludes $6.3
million of capital expenditures of New Jersey Imaging Network. All of our capital expenditures were paid for in cash, and we recognized
$3.9 million in proceeds from the sale of equipment, also excluding proceeds from the sale of equipment from NJIN. Capital expenditures
in 2022 were higher than originally budgeted as the result of the construction of certain de novo locations that became operational towards
the end of 2022, or are expected to be operational in 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I&rsquo;d like to review our 2023
financial guidance levels, which we released this morning in our financial results press release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_058.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the imaging center segment, for revenue, we
are projecting $1.525 billion to $1.575 billion; for Adjusted EBITDA, we&rsquo;re projecting $220 million to $230 million; for capital
expenditures, we&rsquo;re projecting $105 million to $115 million; for cash paid for interest, we&rsquo;re projecting $35 million to $40
million; and for free cash flow generation, we&rsquo;re anticipating $70 million to $80 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For our artificial intelligence segment, we&rsquo;re
anticipating revenue of between $16 million and $18 million, and we&rsquo;re expecting Adjusted EBITDA losses to be between $9 million
and $11 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our guidance anticipates strong results in 2023,
demonstrating improvement in all financial and operating metrics. We are projecting revenue growth from imaging center operations of between
7% and 10%, and Adjusted EBITDA growth from imaging center operations of between 5% and 10%. The anticipated growth implicit in our guidance
in 2023 is projected to result from same center growth, the contribution of various de novo centers opened in the second half of 2022,
and scheduled to open throughout 2023, reimbursement increases from private and capitated payors, new and expanded health system joint
ventures, and the further contribution from acquisitions completed at various times during 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Adjusted EBITDA guidance for 2023 excludes
the anticipated Adjusted EBITDA losses of approximately $10 million from our AI division, which is DeepHealth, Aidence and Quantib. We
estimate that these losses will be net of approximately $16 million to $18 million of the anticipated revenue from both the Enhanced Breast
Cancer Detection mammography program, or EBCD, currently being implemented, and additional growth from Aidence and Quantib AI operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect the AI operating segment to be profitable
in 2024, and will continue to report the financial results of our AI and imaging center operating segments separately each quarter throughout
2023, providing transparency for our stakeholders to track our progress.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;d now like to turn the call back over
to Dr. Berger, who will make some closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mark.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As we head into 2023, we are firing on all cylinders.
We have a core business that is healthy and growing. As we discussed on today&rsquo;s call, procedural volumes and patient demand are
strong and expanding. Payors and patients are increasingly moving procedural volume to our centers from hospital-based imaging operations
that charge prices that are unsustainable in a healthcare system attempting to manage costs. While the shift is taking place, the overall
industry continues to grow, driven, in part, by advances in technology which drive more indications for diagnostic imaging procedures.
Additionally, the populations we serve are aging and growing, and continue to seek non-invasive, preventative and cost-effective medicine.
All these factors should continue to benefit our core business. As such, I am happy to report that the record volumes we experienced in
the fourth quarter of 2022 have continued into the January and February months of 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe we have the best and most diverse company
in the industry, positioning us for long-term success and growth in a dynamic marketplace. In a period where the cost of capital has risen
significantly, we remain modestly leveraged and have more liquidity and capital resources, as compared with virtually all of our other
scale operators in our industry. This places us in the best position to pursue growth opportunities, both organic and inorganic, in a
time where many others do not have the financial capacity or flexibility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_058.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This financial capability will allow us to continue
to invest aggressively for long-term success of our business. These investments include: executing a de novo strategy, completing strategic
acquisitions to strengthen our regional networks; pursuing an industry-leading strategy in artificial intelligence, particularly around
population health cancer screening; establishing a teleradiology capability; owning our own information technology platform; and partnering
with some of the largest and most respected regional and national health systems.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In conclusion, we have never been more excited
than we are today about what lies ahead for RadNet. We feel as if we are better positioned today than at any other time in our history
to execute on the multi-faceted strategy that we have created. We look forward to updating our stakeholders throughout the rest of 2023
on our progress.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operator, we are now ready for the question-and-answer
portion of the call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. We will now be conducting a question-and-answer
session. One moment, please, while we poll for questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our first question comes from the line of Brian
Tanquilut with Jefferies. Please proceed with your question.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hey, good morning, guys. Congrats on the solid
quarter and solid year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I guess, Mark, I&rsquo;ll start with guidance
and your commentary on volumes. Do you think this is kind of payor efforts now starting to show up in actual numbers, their efforts to
move volume away from the hospitals? I&rsquo;m just trying to figure out what&rsquo;s driving the strength in same-store.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Then, maybe kind of related to that, I know that
there are some weather issues that you guys faced in California early in the quarter, and also some on the East Coast. I know the comment
is that volumes have been strong. So, if not for weather, would you have even seen stronger performance January and February?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sure. To address the first part of your question,
Brian&mdash;good morning, by the way&mdash;we certainly are benefiting, and I think the entire outpatient market is benefiting&mdash;or
the freestanding outpatient market, I should say, the non-hospital-based, is definitely benefiting from a shift in procedural volumes
out of the hospital in favor of lower cost, more efficient ambulatory centers, like the ones we operate. Although this trend has been
a multi-year trend, that I&rsquo;d say has accelerated over the last five years, it&rsquo;s happening slowly and I still think that we&rsquo;re
in the early innings of this patient volume moving out of the hospitals. I mean, there&rsquo;s still a lot of outpatient scheduled imaging
that occurs within hospitals and health systems today, that, theoretically, over time, could be moved into the lower cost settings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We&rsquo;ve seen some of the larger payors make
public announcements about their intentions to move this business, over time, into the outpatient centers. Companies like Anthem, United
and Aetna have all been doing this, and they&rsquo;re doing it through various mechanisms. One mechanism is through plan design by offering
advantageous co-pays or lower co-pays or no co-pays if patients seek their imaging outside of hospitals, which drives a financial incentive
for the patient. Then, there are also&mdash;most, if not all, payors today have some form of preauthorization process which, as part of
that process, tries to direct the patient to the lower cost settings or a narrower network of ambulatory settings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_058.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, we think we&rsquo;re definitely benefiting
from that, and I suspect other outpatient players should be benefiting from that, as well, but I think it&rsquo;s happening slowly. The
payors have to carefully balance the fact that they certainly need the hospitals in their networks for more the acute care services, and
so they have to play that balancing game of trying to lower costs, but also make sure that they keep the hospitals in their networks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In our guidance, to answer your second question,
we have assumed about a 3% same center growth, and if that should be stronger, like it has been in 2022, we could end up towards the higher
end of our guidance or beat our guidance, and we have no reason to think that we shouldn&rsquo;t be able to achieve that baseline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good morning, Brian.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good morning, Howard.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think we should call this a tale of two coasts.
Who would have ever thought that we would be talking about weather impacts on the West Coast during the first quarter, as opposed to the
weather impacts we normally see on the East Coast, and therein lies the story, because January was extraordinarily kind to RadNet, and
for that matter, all other healthcare providers, and our volumes, which normally get impacted by both the beginning of the year, New Year&rsquo;s
Eve hangover, literally and figuratively, as well as weather impacts, neither of which occurred this year, so we came into January both
guns blazing and had an extraordinarily high volume, unanticipated, on the East Coast.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the other hand, while there have been weather
storms here in California, other than a perhaps sporadic power outage, we have not seen any significant impact in our volumes. Part of
that is a reflection of the very high demand and backlogs that we have, and when patients are unable or cancel, we do have a very robust
IT infrastructure that allows us to rapidly call other people who have asked to be seen more expeditiously.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, the overall tone, both for January and now
extending into February, is already beyond our initial expectations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think, just to perhaps to amplify a little bit
more on Mark&rsquo;s results, while I&mdash;Mark&rsquo;s comments, excuse me.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Well, in a good quarter, you can attribute the
results to me.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, okay. But, I believe that part of our success
in attracting more volume is not just the efforts on the part of payors, but, really, the efforts on the part of our hospital partners
who recognize that they need to be part of the movement to the more cost-effective centers that RadNet has with them in joint ventures,
and so as we expand those partnerships and as they bring additional opportunities to us, our volumes are reflective of their own internal
policies to begin to be more patient- and payor-friendly and move some of those volumes outside of the hospital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_058.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, I think, if nothing else, the success of the
fourth quarter, and carrying over here to the first quarter, is a reflection of the strategy that RadNet began more aggressively in the
last three years, that&rsquo;s now paying dividends, and I think it&rsquo;s a complement that not only are the hospitals looking to find
these soft landings, but they&rsquo;re looking to RadNet to do that, given, I think, the very strong platform that we have not just in
operating imaging centers, but artificial intelligence resonating with our hospital partners, radiology informatics with our IT platform,
is one that is an exceedingly strong tool, and the overall capabilities of RadNet to deliver high-quality outpatient imaging centers in
a lower cost environment has certainly taken root. So, I think all of those factors really come together at a time where we&rsquo;ve just
laid the right bricks for the foundation here to have an extremely successful 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Got it, that&rsquo;s helpful, and then I guess
my second question&mdash;as I think about AI, it looks very promising, losses are shrinking and you&rsquo;ll turn to profitability by
next year, but as I think about how AI is operationalizing into the RadNet facilities, maybe if you can share with us what you&rsquo;re
seeing in terms of a reduction in reading costs or a reduction in the use of external radiologists, I mean, just any context that you
can share with us, and also the opportunity for incremental, I guess, savings or margin expansion as you roll out AI fully across the
RadNet facilities?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good question. We have yet to realize, I think,
some of the artificial intelligence benefits that we anticipate. Partially, it&rsquo;s because radiologists, and not surprisingly, are
not comfortable completely adopting the artificial intelligence and relying on it as heavily as they can, given that it&rsquo;s a rather
dramatic change in their workflow and confidence level. So, the ability for us to benefit from those efficiencies, both at the level of
the radiologist and patient throughput, is something, I think, that will take longer than we had perhaps had originally anticipated, but
I think that&rsquo;s a positive sign, because once the radiologists get comfortable and adopt these, more importantly, they become not
only more dependent, but, in a number of cases, they will tell you that it has improved their clinical skills more than any other single
element in their history of practice and education.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our particular approach, though, to artificial
intelligence is really for cancer screening and it&rsquo;s not necessarily meant to be as much of the efficiency tool, but rather to broaden
the reach of cancer screening into the marketplace, which, I think, has enormous benefit to population health. We have demonstrated our
confidence in being able to detect cancer earlier and more accurately with the use of artificial intelligence, and as these get further
adopted inside imaging centers and health systems, and as these offerings become more available, like our Enhanced Breast Cancer Detection
program, to our patients, I believe that there will be an expansion of our volumes to reflect the desire for all stakeholders in healthcare
to diagnose cancer earlier, which can only lead to better outcomes both from a healthcare standpoint of our patients, as well as cost
to the system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think this is going to be an unfolding story
over the next couple of years. In particular, I think we&rsquo;re getting a lot of recognition for these tools, and it&rsquo;s one of
the few things in artificial intelligence that can ultimately be for radiology providers and health systems an opportunity for revenue
generation, as opposed to most of the other AI tools which are primarily radiology diagnostic aids and come at a cost, but not necessarily
improve revenue generation. So, we believe we&rsquo;ve made the right investment in these three companies, not only because of their capabilities,
but because of what they represent for the bigger healthcare opportunity to really identify cancer earlier and provide better outcomes.
I believe we now, after a couple years of experience in this market, have identified better ways to commercialize and monetize this, while
at the same time providing extraordinarily high benefit to all of our patients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_058.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, I think we&rsquo;ll be talking more and more
about this each quarter, not only as the adoption of these tools become more available, but also to better expand the capabilities that
we have internally to make these tools that much more attractive to everybody in the healthcare system. I&rsquo;m anxious to be able to
talk more about this.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will also be looking at ways of expanding the
delivery and the use of these tools outside of the RadNet centers, but before we can get there, we want to make certain that we fine-tune
these capabilities inside RadNet on its enormously large platform to both better implement and design the best way to roll this out on
a commercial basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, I think these are things that we will be talking
about more throughout the year and which I&rsquo;m particularly excited to be able to bring to you as these developments unfold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Awesome. Thank you, guys.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, Brian.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, Brian.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. Our next question comes from the line
of John Ransom with Raymond James. Please proceed with your question.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>John Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hey, good afternoon. I was wondering, your guidance
on AI getting to breakeven in &rsquo;24, what kind of revenue assumptions are we thinking there, and then where is that coming from? Thanks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That primarily is going to be driven&mdash;by
the way, good morning, John. That&rsquo;s primarily driven by the rollout after our successful pilot on our Enhanced Breast Cancer Detection
system. We&rsquo;re now almost fully rolled out on the East Coast for this, the last of our regions will go live here in March, and the
West Coast will begin rolling out sometime in the third quarter. The revenue that we expect from that alone is somewhere between $11 million
and $13 million in 2023, and then growing substantially more than that in 2024, as more and more of the markets are fully implemented
over a longer period of time. While we expect some growth in our Aidence and Quantib units, which do lung screening and prostate screening
with AI, we are working on ways to also commercialize and monetize those, but they are probably a little bit lagging behind, since our
primary efforts in this area were really in breast cancer, given the enormous number of women who get breast cancer, one out of every
eight, and where the amount of mammography done all leads (inaudible) any other application of artificial intelligence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hopefully, that gives you a little bit more perspective
there, John.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_058.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">John, in our guidance, we&rsquo;re assuming $16
million to $18 million of total revenue in 2023. Although we&rsquo;re not giving multi-year guidance, if I had to estimate today what
that revenue might look like in 2024, in order for us to breakeven or have profitability, it&rsquo;d probably be in the $25 million to
$30 million range, based upon where the expenses are in Quantib, Aidence and DeepHealth. That shows a lot of growth, and that $25 million
to $30 million would likely make us the biggest AI radiology company that we&rsquo;re aware of.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>John Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, I have to say you guys were AI before it was
cool. Who knew a couple of old guys from Los Angeles would be that far ahead of the curve? That&rsquo;s all for me &hellip;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hey, hey, we&rsquo;re not that old, come on.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Speak for yourself.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>John Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;m old. Thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I like to think that we&rsquo;re not ahead of
the curve, we&rsquo;re making the curve. I think what we&rsquo;re doing is very unique inside healthcare, and, in particular, radiology,
and I&rsquo;m extraordinarily proud of the companies that we have acquired here that will help RadNet continue to raise its visibility
and not just be a name for radiologists, but be a strong player in the healthcare industry, that I think I&rsquo;ll be sharing more of
that story with you later this year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>John Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, John.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. Our next question comes from the line
of Mitra Ramgopal with Sidoti &amp; Company. Please proceed with your question.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_058.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, hi, good morning, and thanks for taking the
questions, just a couple from me. First, just as it relates to the de novo expansion, how quickly do you expect locations to, at least,
breakeven, and even become profitable?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Well, if we were building a de novo center, Mitra,
it probably could take a year to get to profitability here. The difference with our centers is that, by and large, they&rsquo;re all in
markets where we already have demand and where we can anticipate filling capacity almost, literally, the day that we&rsquo;re open. In
our model for these, sometimes in the first quarter, or certainly by the second quarter, after they&rsquo;re operational, they become
EBITDA positive generators. But, again, I think that&rsquo;s an unusual circumstance, given that we build these centers because we need
them, not just because we think that there&rsquo;s future opportunity. So, these are all responsive to the growing demand that we have
in our markets and where we&rsquo;re limited by the physical capabilities of our centers to ramp up.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay, no, that&rsquo;s great. Then, just switching
to the labor front, obviously, that was a headwind for you in &rsquo;22, both from cost side and also being able to staff your operations
fully. How comfortable are you, in terms of &rsquo;23, in what you&rsquo;re seeing out there, given the expansion and more locations you&rsquo;re
adding, and your ability to fill open positions and being able to have adequate staffing without necessarily incurring significantly higher
costs?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, that&rsquo;s a great question. We&rsquo;ve
been very fortunate that the labor markets in our centers, and in the regions that we operate, appear to have loosened up, if you will,
a little bit, and while we still have a number of open positions, we&rsquo;ve made some good impact on that. It&rsquo;s hard to really
put in perspective how significant the labor market challenges were in all of 2022, including the fourth quarter. While our results were
extraordinarily good in the fourth quarter, they would have been better if we didn&rsquo;t have some of those challenges that, while we
were turning the corner, were still impacting the fourth quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;ll give you an example. In New York and
California, the state has mandated that any individual who believes they have contracted COVID can isolate or report in sick and the company
is required to continue to pay their salaries without them using up any sick pay or PTO. That&rsquo;s a double impact for us, because
not only does it cost us double to find that capability for coverage, but because then we have to pay more overtime, we are getting hit
with both of those. Unfortunately, in the first quarter of last year&mdash;or excuse me, the fourth quarter, I guess it was, of the year
before, we had close to 8% of our workforce out at one time with COVID. Currently, it&rsquo;s down to less than 1%. That has been a huge
benefit for us. So, it&rsquo;s not just hiring more people, but it&rsquo;s getting our current workforce back into normal workday, which
allows us to expand our hours of operation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we&rsquo;ve been using temp agencies
and locums temps businesses, that the price for this staffing has doubled or tripled from a year ago. Fortunately, we&rsquo;ve been successful
in hiring more radiologists and other technical staff, so we&rsquo;ve been able to reduce that. Built into our 2023 budget is still the
use of temp agencies, but as we&rsquo;re more and more successful, hopefully, that cost will continue to go down and improve our results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I believe the issues that we&rsquo;re faced with
are faced by virtually every healthcare provider out there, as well as other segments in our economy, but I believe some of the changes
may be, also, as a result of the economic factors that are causing layoffs in almost every other industry, except for healthcare. So,
I believe that that trend is not only sustainable, but will continue to improve as people seek alternatives&mdash;or people have fewer
alternatives than they might had before, and where I think pressure on wages will start coming down.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_058.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay, that was very helpful. Thanks again for
taking the questions. That&rsquo;s it for me.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, Mitra.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. There are no further questions at this
time. I&rsquo;d like to turn the floor back over to Management for closing comments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. Again, I would like to take the opportunity
to thank all of our shareholders for their continued support and the employees and Management of RadNet for their dedication and hard
work. Management will continue its endeavor to be a market leader that provides quality services with an appropriate return on investment
for all of our stakeholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks for your time today, and I look forward
to our next call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Operator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That does conclude today&rsquo;s teleconference,
you may disconnect your lines at this time. Thank you for your participation and have a wonderful day.</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !< + # 2(  A$! Q$!_\0
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AQ&,=>O0D4DNFV4ZQ+-9V\BPC;&'B4A!C&!QQQQQ0!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_057.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_057.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '[ L(# 2(  A$! Q$!_\0
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M^WYT>8_]]OSK9Q24>S\P]OY&/YC_ -]OSH\Q_P"^WYUKTE'L_,7M_(R?,?\
MOM^='F/_ 'V_.M:DQ1[/S#V_D97F/_?;\Z/,?^^WYUJ8I*/9^8?6/(S/,?\
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MDI@%)2T4"$HHQ10 E)3J2@!*2G4E A,4E+13$)BFTZB@!M)3B*2@0E)3J2F
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M4M% A****!B44M% A**** "DI:* $HI:2F 4E+12 2BEI*8@I*6B@!*2EHH
M2DIU)0(;12T4 -HI:*8AI%)3J,4 -I*7%%,0VBEHH ;12T4"&XI*=2$4P&TE
M.I*!"4A%.I*!#<4E/Q32*8AM)3J2@!*2G4E,0TBDIU)B@0E)BEHIB&TE.(I*
M &T4M% AM(13J2F(;12XI*!"44M)3 2D(IU)0(;12XI*!!BDI:* $Q3<4ZBF
M(;12D4E "44M)B@04444 &****8%[2?^/IO]P_S%;%8^D_\ 'TW^X?YBMBN.
M.QZM3XA:*2EID!1110 4M)10 M%%% PI:2B@0M%%% PHHHH *2EHH 2BC%%
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MEI** %HI*6@84M)10(6BDI:!A1110 4E+10 E%+24""C%%% Q**6DH$%%%%
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MX;_=_J*TJYX;';5^(=124M69"YI:;2YI#%S2TE% "TM)10,=2TVEI +124M
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M_J*OU0LO]<?]VK^:RAL=%;XQ:6FTM69"T[-,I: '4M-!I:0Q:6DHH&.HI**
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M:6D,=1244#'44E+0 N:6FTH-(8M+244 +2TE% QU+3:7-(!:*2EH&+1249H
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MT]/-U7/VW>[.LV<Y!5B0!\QX '6L8?"?P,()X1X?AVS$%SYLFX8.?E;=E1[
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M#NQCY1VKQ77M/EM?#GA?5PFAV*W5PCVMMIT!$P7KN>5B78@X')."?:O2K_\
MY.1TO_L%M_*2BX^5(Z#P'XPU#Q1J7B.VOH;:--,O3;PF!6!9<N,MECD_*.F*
M[:O*?@__ ,A[QQ_V%#_Z%)7JM-$RT8M%%%,04M)10(6BBB@84444 %)2T4 )
M1110(*2EHH&)1110(**** $HI:2F 4444@$HI:2F 4E+10(2BEI* $I*=24
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M,0 .<=>_&*5[%\J;T/;/%/C+_A&M=\.Z9]@^T_VQ<_9_,\[9Y/S1KG&T[O\
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MZBLK'JU%%%42+1249I +1110 4M)10 M%%% PI:2B@0M%%% PHHHH *2EHH
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8:*2EH&%%%% A:*2EH&%%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_058.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_058.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  I L@# 2(  A$! Q$!_\0
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M51ZDG@5G6_B;P[=B4VVO:7,(EWR>7>1ML7(&3@\#) S[BBT1<\^YT']L1_\
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MM*AL?V[!_P \+C\E_P :/[=M_P#GA<?DO^-9_D>U)Y'M1RQ%[2IW-#^WK?\
MYX7'Y+_C1_;UO_SPN/R7_&L[R/:CR/:CDB'M*AH_V];_ //"X_)?\:/[?M_^
M>%Q^2_XUF^15&34M*BU)=-DU*S2_?&VU:=1*>,\)G/3VI\D ]I4.@_M^V_YX
M7'Y+_C2?V_;?\\+C\E_QK-\CVJJEU8RS"&.\MWE9G0(LJEBR<.,9ZKD9],\T
M<D!>UJFY_P )!;?\\;C\E_QH_P"$@MO^>-Q^2_XUCW!AM+>2XN98X88U+/)(
MP55 ZDD\ 51L-9T75;@V^G:OI]Y,%+F.WN4D8+ZX4DXY'YT<D ]K5_I'3?\
M"06W_/&X_)?\:/\ A(;7_GC<?DO^-8MP8+2$S7$L<,0(!>1@J@DX R?4D#\:
MD\CVHY("]K5-;_A(;7_GC<?DO^-)_P )#:_\\;C_ +Y7_&LGR/:D\CVI\D ]
MM5-?_A(;7_GC<?\ ?*_XT?\ "0VO_/&X_P"^5_QK'\CVH\CVH]G 7MJIL?\
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MN=2LX;.;'E7$DZK&^1D;6)P<@$\4>S@'MJO](ZG_ (2.T_YY3_\ ?*_XT?\
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MK?EM;.=I6FM+>1I559"\8)<*<J#D<@$DCTS2R6UG,+@2VD#BY4+/NC!\U0,
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M\K=Z[<8S[XHY6"FCG=#O8[;P5I%O;64-WJ]Y:R06497_ )8;CAG;JL(4H3^
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M]X;DW6E6,YNBAN#+;HWG%!A-^1\VWMGIVJW;16]G;1VUK#'!!&NU(HD"JH]
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M% X]"36T)?\ BM;+_L):S_Z''7?3Z)I%U>->7&E6,UTZA6FDMT9R 00"Q&<
M@'\!3WTG3G#XLK9';S/G6!-P,GWSR.K<9SUQSFEJ.Z,;Q^F/A]X@/_3A+_Z"
M:AU&ZUW0?".J:I<7%A>R6UDTL$<%D\6UE4G+9E?<._&.AYKHUL+3^S%TZ2!)
M;01"$Q2J'5D Q@@]>/6K&%V[=HVXQCM3)T/)=;U#5V\-ZM:ZA<RB%(K*XCN-
M0>T\Q&-PH+%+=R/*X!!.#PPR>VMJ&J:S8WMWH\6KRR[+^P@6^>&(RHLY(="
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M'R/:HYH<0R''13_*M+945R@%K-_N-_*FI:B<%8U-*_Y ]E_U[Q_^@BBC2O\
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M_P 51_PBEQ_T%3_WX'_Q5=-11[27<?L:?8YG_A%;C_H*G_OP/_BJ/^$5N/\
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M_?K_ .RH_P"$<OO^@W+_ -^O_LJZ*BCGD'LH=CG?^$<OO^@W+_WZ_P#LJ/\
MA'+[_H-R_P#?K_[*NBHHYY![*'8YW_A'+[_H-R_]^O\ [*C_ (1V_P#^@W+_
M -^O_LJZ*BCGD'LH=CG?^$=O_P#H-R_]^O\ [*C_ (1V_P#^@W+_ -^O_LJZ
M*BCGD'LH=CG?^$=O_P#H-R_]^O\ [*C_ (1V_P#^@W+_ -^O_LJZ*BCGD/V4
M.QSO_".W_P#T&Y?^_7_V5'_".W__ $&Y?^_7_P!E7144<\@]E#L<[_PCM_\
M]!N7_OU_]E2'PW?,"#K4A!X(,7_V5='11SR%[*'8AM(/LMG!;[MWE1JF[&,X
)&,T5-14&I__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>rdnt-20230228.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOa2N6aPty552qYkxvmRzfdlarycsEPy0xCjYwJ+GsbQF -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:RDNT="http://radnet.com/20230228" elementFormDefault="qualified" targetNamespace="http://radnet.com/20230228">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://radnet.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20230228_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20230228_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>rdnt-20230228_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>rdnt-20230228_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://radnet.com/role/Cover" xlink:href="rdnt-20230228.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://radnet.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140381906829712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 28,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RadNet,
Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3326724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1510 Cotner Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">478-7808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.0001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RDNT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>radnet_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rdnt-20230228.xsd" xlink:type="simple"/>
    <context id="From2023-02-28to2023-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2023-02-28</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-02-28to2023-02-28">0000790526</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-02-28to2023-02-28">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-02-28to2023-02-28">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-02-28to2023-02-28">2023-02-28</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-02-28to2023-02-28">RadNet, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-02-28to2023-02-28">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-02-28to2023-02-28">001-33307</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-02-28to2023-02-28">13-3326724</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-02-28to2023-02-28">1510 Cotner Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2023-02-28to2023-02-28">Los Angeles</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-02-28to2023-02-28">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-02-28to2023-02-28">90025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-02-28to2023-02-28">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-02-28to2023-02-28">478-7808</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-02-28to2023-02-28">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-02-28to2023-02-28">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-02-28to2023-02-28">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-02-28to2023-02-28">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-02-28to2023-02-28">Common     Stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-02-28to2023-02-28">RDNT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-02-28to2023-02-28">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-02-28to2023-02-28">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M1S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ X7-A5I>*NQS
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M7F=Z_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%     @ X7-A5B0>FZ*M
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #A<V%6T82!^.\    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #A
M<V%6F5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( .%S85:$*_GL0@0  '$0   8
M  " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #A
M<V%6GZ ;\+$"  #B#   #0              @ &&#   >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( .%S85:7BKL<P    !,"   +              "  6(/
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( .%S85:JQ"(6,P$  "("   /
M          "  4L0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #A<V%6
M)!Z;HJT   #X 0  &@              @ &K$0  >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " #A<V%699!YDAD!  #/ P  $P
M        @ &0$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"
(  #:$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="radnet_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://radnet.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="radnet_8k.htm">radnet_8k.htm</File>
    <File>radnet_ex9901.htm</File>
    <File>radnet_ex9902.htm</File>
    <File>rdnt-20230228.xsd</File>
    <File>rdnt-20230228_lab.xml</File>
    <File>rdnt-20230228_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "radnet_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "radnet_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20230228_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20230228_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20230228.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "RDNT",
   "nsuri": "http://radnet.com/20230228",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "radnet_8k.htm",
      "contextRef": "From2023-02-28to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://radnet.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "radnet_8k.htm",
      "contextRef": "From2023-02-28to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001683168-23-001214-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-23-001214-xbrl.zip
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MQ95>)F7@*(YT$[-#"*ZC>'C YUX:%GI'#<?@G2+3ENX!A#/9&*D$5D75Z<S
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M$%I]LWE225:,++GY_;OOB<'_ U!+ P04    " #B<V%6#8:7]IM8  #P/00
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M'=)5#7BZ,W4!R83QX_*FVW'>!D,#PCT1U25*G6CX EPB6&J,P5(R8L:$F\X
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MA#%8O)\I'!+0F:+&)%[3V"N&C)"+EF\7F6SBPLVW...>4^_T1+^A)*H8SNW
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M=F(J\Z9>9I[PJ@8CQ>%%O/O8BV8,)$0U&8K?7-*Q!R-12?Z)]0<JSXL.&E$
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M#[W-<YDF*;]M)7H?4.(TTO!8L0&0#\:.N.TBY)>K-G@CHB0\>\#@\E2@@I!
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M,>[?JR40Z2&9:G6E7"G3>B6+HF:I!E2LM*TBEE9ALQ.TK1*A6'S35];P"F,
M7Z6862DJM"S'N%8N9ZXCJN.=J6_HWC@U07/BT6L:$FN1IKGV53JFI8!*E3HM
MU<H9I. 2+59JM*S43HV&KR2)=GK?FO>YJ'G2&SN$J'GQZ:ME:5C/.[W K%2K
MM%+)(@TJ2PJMR<53HT )Y,9/'%'-!YUWUDH[9RM6J"QO2_O3N+-RA8*P>@*D
M)]&/P@L=LZ!JMU^Q+;W@EJE<V_8"IW-?DK(MR4T!86KQ_#:O(?M<&_7T K]<
MI;7ZMG<XC1LKP761ZZ=.G%SUE\?@J-]?W?<K8 8J3\Q-ZPG\P]149Y1%F5LJ
MT5KYJ(QOCQ:Y&\9KE$;<OJ_->*10J9K[>;<!H5*A127C?M[XF<DBD5%8Y3:T
M7<NSR9 KGSQ_CVC6%%2BS<+TMATVD.9*BD+KQ9C#(G&G^[Q"&0!EL5RCI>I2
M7\!FH$R;.=&/Y;]M-3ZW;EN]5K/+7=KHX.[]F5YI(#<M'E^$7LE2[2<=1! L
MX\#/[,:.+CQ'0KHGZK.(YU8' WO*D@(GTWL:2J5.R_4L6KSE"H@ARE'C)K8,
M\\:VHB<0Y"V#OE3,I&%2H64E RZ3P)KD=U"(- ASK*&+K<Z)HQII1C*,O<YB
M=)=4I-7BMAL[%I&ZGC5%\LIBL_%<Z05\N4HK<24U QA5*=-2^:C937LT3B9@
MG&EAJ7!/"!/ML+&F/S;!XCW<7IGI39)I*<Z-<^OE.B#$8+2]!&"FQWHYGZ4"
M0J9?SSV]I*U4J="JG$5OI5(MT>KI912N9':Y[;2_7O6:]]]SP\OI;^Q8HN9<
MGL#I><,KQ1*5I"P*G&4,FJQF((*G'94D3P_#:DJ=*J4L)G)62PHMU8\:/K^K
M8!Y?SGI.+[3K5"['JJ]D (MV$X]T=#JU*)&.QT5CE?_U1?JL*7"R0HM2C"'E
M.O Z.G"%*I6]F!'2IP.?A.XKT7I)IJ5R%EUU$JU*,E6VEHZ/K_]>?,JC54YY
M8\>2$:.=*K KX^#G"+")]UG$I%[W^7W& 9_9C1U=7KSX=&V-Q]B4"-&*7)'?
M"L5B4<*&2^11-::@Z<K%(BV*_Q%GI&*_G+!]WP=2KJ+5E4IRF;M7RJ",E6$]
M<M5_6'<<C'OAX2Y3%[NQ\>ZBJCM3Z)I@-6;^T/RW$O5[_NJ/S$BQ:I1%M>BH
MAILM2&;#:WB&%1!47;O20?-1)SH(=.F%=4FI4+F6Q5Q0!833<OWDW<X\K&\Z
M]AJPA6W2;#9BIH.]E"ZQT>E;;"9FC5,<WG I%VFENHE _3;=FRIM% ;T]IBT
M:H%M((II&AOJ _VUQ2I<UF1:V5U)S668FSGPU14J[RY3;1=W9 4:O)6I)JHG
M_;>3J"FEEWPIBDSKV8RUEFNT7CQJ^,*NJ7,;FZZ;KFT9!N^&ZW6J?6VF= DS
MT.)EX'-;^EKQ9%4JQ_/%CVY,WQ>Q7G!^@H*O1*2SA@&ENI04E)O?HG5RRDL5
M*NV'$J7');4DJ3SBJ0JJ\VYPF3*0&9TGF9]8DKG78W:^%R4.)T;:00M3?^)3
M;L-ZD#T<%E O-(ZNYHVC9V_=/AI'5_/&T;N^*/%G7V]KY&X/_L$&%%W2^4*P
M+46CUX('3JU)\N8HM&0Y HG(\G_R=LTOREX)T3:)<E?0254J;MVO^4^FV@YI
MFAK34M.U>1659Q%0=]'A-P'2F6CE?,JPV4\KYVS 9L,PUCW>X%7FNF_^T6S_
M:&YF],]V3^N4+&/?QE>/+9?+J[6\!:[\J(-</V3,K_2Q0+X_5@?@I>\'\<!R
MM4:+T@Y[ )\@#+ #;[44<QN\(AC40="JQMG^D3I![]K#>.]5XX$I,,J(QZ[Q
MHA:J;:OF QLG=3'/N)%?*LNT6,I3=[:"8:E&E7@'^1R&:\&P2"4I%JAY=&?3
MVB[;B'BY2GS- KDA/9$F$BTI15K,9*='B2I2F18WBMI,_]Z*58G62D<MI[==
M4]1''?FTS0R=#<EPRG,<T@OP['9?J -ESF2YR4IFNU5[3H'V5]+\]UVSW<WK
M_^0;2]G&CE9#TW+<2.%,RW0H8;\&QI2GT&EL8K.![NF%ID;4,9:A^8^:[E(T
M$E(RJI2RF"\G44G&N/LL%MJI8Q?U8@:RN&YY,W&U#U?&,GE/ML%(M1_27. A
MNP*;5-]!?; T;BP%%86VJDMUFKP%=.1:)G7D>H56ZEED*[4*K6Z=]Y0&KF(Y
M#L%*"JI7:5K3G8D%?Z$ A['8$\YJ3J#MATS+6S?'3..^0/#,J- I;]UBXUA\
MQK\U^GBBZC;>D/3".;M"6'9W5J)2]>2[M"QPH'49+$/%:.U5FI-GS0M7C]/R
MW(NY!ORJ\6K .?S62=ND2@K3=E=+.%S1\?MBKF[8S,=O:??*$$"B2DT!I6PO
M@0"O"(IR2:(592]7Z15!L5B1:6G3:.:4R3\KN0U;[>O.]R;Y<M_Y/I-7E%I)
M%(LF9[$]34VFY7(6+5-*F5:.VW9G1<4Z_:#,W<NO<F/IY!R=WK?F/?'X!V\B
MG\>=Y!M+X\:.995M>07-?-4NO6 N%VFME,5XWU*-UK;N+YW*C95IK9:!*)(F
M+Z]$=),PU39!QW+0T?>7I9LN>62F.[73'%!R*16I4M\$O])< A@V5:]DK:YQ
ME=;C24^K[^E8/*2-W:949X3!5>8#PXLR5'6OK0!>%;]J)K%5EY$1TQY2S&<N
ME3JM;%-=.I6;DB5:V<@]EN)-8?3"4;L![C"<Y/)!U<VWZ!^'WX'%3'5GQ*-(
MX/I@^W(>36(S429\13/\$8^FJF114JO08B8;:UZ68&-;,--4Y5.+#HBOUE-5
MR_TK6T*PI.1^OJT@>)J^J3WXS5\S)5) Z<S#3K:!H*PDY4OD(%P'"2NTO!]J
M?AB19QWW^.5MI]M]2SXWOW3NF[[/H]?X=YJ='269UBM9#$ OUVBMFL6-7=8V
M"@ X2E.A[7@X+_7@8%+4T+*]1F_$57^].DY^6:=*O-!*WIUK1>A))5K>70OU
M5P>^6CQC[)B=S7;+NMO-'IEAW^DE_ I(H\4LMBPME:@B99)52[1:VF1C)\BL
MV\SU6;3JNK;>G[IJWP!^;1$S[^ F>O/1>CDW;&UEV*HG]3;.0;@."!5:K.],
MELRC;_,@NWQC!V?5R0W 5A!X%_1-\Q[438UASY$KWDHM)AJ31J]WW_K\0W0[
MZ77(3%,<>/![IPWK[5S_[[?.[4WS?IG9*X--W*0BK927JIIY,[RELE*)5N6\
MJ>#6<$3;1T*MU\T!>4 -_I5PCGQCI[:Q#/+ZSXUNZYK$.7[8H2WG_<MPJUB(
M&[%RCK4^%.-Q<#D4U^;[Q4*\K-A)</U5#B.51[F&R6;]\TP>/+OW(@=F#LQ,
M"EHWK=L?V*LW%[6V%+5R(6$7HM;2LFXY%+,K:KT2=3W?V*EM[/BE3"X^_:O9
M^OH-.77CC^9]XVM3\.8NZ?SH=7N--C9YS_@IY!L[M8T=KYKE J[^677T07I%
M@KTJ1N4*E>L*5917)&/M%Z R+6%GAGA4?P[0S0!:I+6Z1*O+PX%.07U?CS+=
MZ,;49=IK/?DJ560X_7@]BOPJ;090A99DB1:7IW[G $T7;7K'S6SP&?_[\2X*
M9C$2Z>ECYI V>R+WUE@UJ?B"DBZS]>$',E;M!QWFP$>+X21WG](Z8##4?UU=
MD2\Z,[3WY$Y]@(/ILK^GS!P "&ODZLK'FYO6'_Z<8J0 ]!6$\\M!J3"=L&->
M-V]O[QHWJ#?]?E&\X']W[QK7_M^SZ -,P% G#JS$__2!/.F:.\(=%]_$CANG
M6<AD7&N2A X1G/*&5I0WB]#:?Z+T9G:H <-H=A@L DP?C!]([WD""VS8:E\?
M?"!M=<P$J-L6PK<6?>F=_Q;^LFAVY<U2Y0$1VT?JC^_@[!*.L6\S]>=5GPTM
M&Q8TX6?O'2W BI\K[.AN]M0Y_D31<6;TZ$YPAP)_]GH!XL<@T$)H\&O,)#;-
MB<8<@O,=SYC?L81I]\?G;NNFU;AO86;OL99UW6EW.[>MFP8:*;H]^.=[L]WK
MDLX7<MWH?B-?;CO_.N+R+EMMTOO6^=$%B&%6U;;D:\ET DE(TC_^W+/S!T@6
M0["]T:M5MGNQFL2\,^-NHH-K]8R'ZPX"I?W[A12"9%T7FH^%RQC)GTRU'=(T
M-::1&S9@XSZSB2+190)"<BY#@LEO(]TE=2<AS^/FZNDB*QW4Q2>Y*&^8@[,$
MZ-F S8;)-:\"-AMF8>_JLAZT]'G(A6<:9[2_DL9UK_5'J]=*<V&0W-+^*C=V
M,!>")QV5RW%E+FF-D?3B2\-RG%B>OC>>G*0;OG0DOI2VVC)B003^ZTO??S&)
M?[U%O*BAIAT R<G^KP@ R44!UEM$FNL#7'QJ:']-'1=KYSJ8_F^S@64.=(,1
M,[C$XCRP-@!\Q2M73[#8#XKV_>=(NSMUX.J/NJLSYWW&"6^^L5/;6'IZ1UY\
MNF$3N&8Z7!K+Y(6JU;$%2_D/_R*]YR!)95JK;E+W..T8AH[J>/7-#&RL5J'5
M>$&H4_0,)S"NR*7!LN\A'^*;O[*&5U.'$=5QV-+J-4<\HDJ-UC8J)IYVW*LJ
M&[8<2?O&*E5:EXYZJ7;,CVZ9BA>E#ZS(,GD7A<%(M1_2W##A'Z8&<F@6I1VI
MGE3&. ,;V\V1I909Y3VO4KFIO.?5(3)5-E6#=$>4'@0!SB%#VQJ?S(4I)76]
MR "-+M%J,8LB6YV6XU[0;'">&34(C0E/-MQ2X#Y#T0MKR&R;:62HFZHY0.UH
M8#FNPY\T+-4DFNX,8*5N>@]/!N4\B^WA%2IGLCL\$$=IV_-*$Y_B#>?@<CFJ
MP?B]@2LSL1SL6#,D# 2_">I,Z3T/[/N7Q8+-$I7C*='9V%=QV_[&*656*_5N
M3._)9-CJ@-E:&=Q7*ELU;LF']/%$U>UT\YSLWI3L[JQ$I8U:'I\ WYGW%?$@
MAJ%A/:6]N[9"*[4L*N2PKZW]DNG<5ZETU![;.^8Y>:_ZU)N$KS;N59_VRW0*
M#>LWO%==UQK\O.JK#M/(P!ICR]N41__("JUF$\O*H&]GT;XHR;14S%*<@FA5
M;X((QUD2C#U&AK16W^A<<\AWM@YQ*&74;70=R'.!*(=MWV D'O]CF8ZN\7BZ
M-/.D2T7>PA>>QAUE]R:E(/QGI^S(^V:V8+"X50[G2F%:!(] %1Y77>WK!D^1
MH#R; JZ=__/@[ZF.GMJYY_#WZ1B^AS$G4QOT,(<1UU9!8!SPR(D\UR+?6+HV
M=EB6)Z]L!!SP0 <'<YR8_H@-3]-[$)=*D1:KFVB_*>9NEV5:RUJ8(5<?MW6=
M'8"MK7Q-A)8UF-HV2H)I3Y^X5*@2[SUWVBAU*95I=:-$JQ1OJD++M=,RYJUY
M8U)_4R292I5-*%6:L:JRK7Z>QET!GRQMH]FFB9W<^!&HKOHKS=8Y"1A).8LA
M,%*=UI0LQIE>5J0M7'EIY26!V<#@67F^)> YS>=0H_72)AZ4%#.6RZI,R^6L
M;:JLT/I&RDJ:&8O-'IDY3;,N7Z6*E#'!ZU*N)94&.NU-*9A=MPE/2;V2LJ#(
M8& 2FZC/: ^C1!T,["E<*M^=RLW1W,.Z%"RKES'T1EB[=.&J9[W5P'XT9!UT
M\)C"NEH%Q(UQ,EL@K"?52<@AN X2EFFQLK2#RB8@/  G5[8B3>U5:XV],I20
M2A5:6MY0,[]6+\*P3DO+FU7D,'S)[Z$HM%I.'VTZ6(7@5ON/9C>O$)QO+,T;
M2T^\S,6G.S]Z!=,&QNH#LO&A.@CB7'Q%P^?REIEB<_&E)(-X6\E8+L%EM4HK
M<<9XXIM2)"I7CN5.V5\(9_0^@9 ,E\9]YK?H!&H27$H2B&#EK&&:I%1IK;J)
MLR7-NZIC9N@F?M84)E'/,"'35<T'O6^DOTIH=N."+\M44C(6$Y:"6.<]LAW;
M&C"F>17;>%&<TZB#@[ZO+/K!*QN%BJ1]5[7CIG[N.%<@T?;C%0W%O)NP#B*6
M$/VE.\+("<+<9)9AB61K>&BM4HE9,SY=2K04=]1M:GM:QDERZ.70FX%>1=F9
M6^LH*N:./#-31Z0EZ>8C<UZW5^92+E5H/=XI*+]4J\)/EF@Y'L^7PV]5HB17
MJ%R*B;?')$N+1*C=N%^^M-J-]G7N?LDWEN*-I56%5Y]%PS>L:LM,W<*J&FZ:
MH_,Q<K5:SIB9Z+(BU3>LS9OF7944*F]43#2-YF);-P?Z1#4P0C*X,_RRB$1]
M#-(/PB?3>R@9MA\K5"ENX9Q(Z9[*&R6VI=MAV8"WT,@%MVFN+P'SNA+ W;+9
MHV4\\@08;$^@PJ73TFU7SO#=JF_4Y23--ZNZ47Q_*CE3U V#==.)[CA3O$Q!
M:1G_"W&[TGLJ4JE*ZYFL/UZ5JL">LEC!]Q7Y.#UUB<"W+N-%E_#C@ZV.LWX\
M^<X.N;,2+<I9:IPSV^!MHNH:=I@W+9-[/"W#0"G/]VFFF#U=UC;J/Y5F,4BF
M)3EK&:D2K=<R&.69&&ZSX!*E]W2R2[4EA1:K6:P?G0();Z\Z4VAI&-A,TUT_
M&2'%I38R?(NPGL#6;<_2N#.Y7*3UK#9TBWJ2\ON4HIU=;GZATBSC;7Z94F?"
M6Q"",LNC @L>K\\^'J/#%EN'D.F$]T]D]D 7L:'69)6,N:S%O<CUG86\K(B5
MV8)?*5Z3,X??&O!;P$!.(0M^[\4Z+KWXT+=B5^+_PS[DKS96M*[02KPG:7[M
MUBG@42S12ESISF&X3LAHJ4S+\03V[$2,-K]\:5[W2.<+:?[[^ENC_;5)[AN]
M)A&?NZ33)AA4FEYI5Y*R:%:ZW"85/Y4;DHHIKD.[V=UI-WOD\J9Y?=]L=)MO
M2:LM/L$'?F=(HWTC/C3_^:/U1^.VV>ZE./KZLD*KVR2PIW%/BKR#@OIIW%A%
MHK6-"N_NW>J\R55:(#4LO$24]-F#;IHH(6-=#V;KEO;*)!-) >DN7J8XE^[6
MDI!E6I1RY7XKXTB12G%AY11T^]U0*KE07D*K&-;LVIA*>>.OC1_\/:)9T[[!
M5@+];RMAQQK#!DZK:E)OA<1][O.:G3X@5Z/X.2!W1/8W V1JA*J+3]T?=W>W
MS>] A1JWY*;5O;[M='_<-U'9#Q)%05GYTKG_WNBU.NWTBKMY N6KW%A*_?G7
MW(B/D9K:U$8=Q!TQC[W#Z_;! LUB]'$EE;A.I8U*"AX&XS;:DURGQ:U[D*=L
M3PIFO1ZUS<:.X\J6WYJ!-6:'Z8"VT8F4:^E-4=EH0Q*M;Y0MGN(M);:"V/32
MO.LU/M\VX3/^]^-==#@Q$NGI8^:0-GLB]]98-:GX@I(NH/7P QFK]H,.<^"C
MQ7"2NT^O9L!@J/^ZNB)?=&9H[\F=^@"">I?]/67F ,ZD3JZN? RY:?WASRE&
M"J3Q"A[<RP8+F(Z?&+ENWM[>-6YN6NVOOU\4+_C?W;O&M?_WK#H!Y,Y0)PZL
MQ/_T@3SIFCO"'1??Q(@;3K.0G+K6) F_(MCH#:TH;Q;=)/^)TIO9H08,!0L8
M+ ),'XP?2.]Y @MLV&I?'WP@;77,!*C;%L*W'GWIG?\6_K)H=N7-4L$.;XI_
M2SZ^@[-+.,:^S=2?5WT&)!X6-.%G[QTMP(J?*^SH;O;4.?Y$T7%F].A.<(<"
M?_9Z >+'(-!"*%]KS"0VS:G0'(+S'=\W;MK-'D5?4H&;D[H_/G=;-ZW&/:_<
M<ZQE77?:-\UVMWE#X%.W<]NZ:?2:B#'P#^J77=0I.W?->ZY''G&AEZTVZ7WK
M_.@"[+KHTF[>]4CW6P.T7H0FK-#["S;0>'N\=<[BV>P: I2,H>/>J-LJ=^5B
M-4ERN?5B9>4PP<BQNNW\NH- :?]^4;E89X(D!%C&=7HCFS'R'08;.:1I8F37
M#1NP<9_91-DP=B2VM T%^]0=ASR/H*M['U8Z+M &BW),%]P)T+,!FR,CY$$C
M-.Z;?S3;/YJ;J2H)Q[(SR]=V2M3A5G88:_9N5<Q3/K?#'](*=\\3%RJ5N"Z4
MZ'9@]J,.NL40F.*"ML/>B'*2<O62V< 77%9;2,R"X+^N+'O?M\&5*E2JQZP^
MZZWB11TO[1"0ZQ4J5V+.V\TA<!R"LH ;WPOL)# %B&H#=:*[O*4646U;-1\8
MS]I[9?$<2I56\I:^VX&P0FOQ(@NG$!*S89?YGN6J1OI;S"LUA=:J6>P#HB@*
ME;:VY1]+V+L3^5 V8)"ALR$9PK" A>D%=W8SHF5:DW;F/TF5*NA9)]M?2?/?
M=VC+3'$H?AX5DD8R=6TYKD@B]SNO4L)^#8PI$BNBL8G-!KHG/YH:4<<6+.H_
M_(OTGH@BUVFYMNV53^/.Y%J)5BK;NNP/3LSBR[G%\ME$[0-262:OL3@8J?9#
MFBO19Y=!2G50C[85(8]%P6Y.E$85X2)G,8M++M/2<6.\=D2A+$>TR<#">XA7
MFNY,+/AKINEEV+P\O2<BT?+6+".E^Y*W;>N9*M-=E\'<*Y?MSIJ%J137]7,+
MW5H5D4[1.K?I71'F.4]M 56%_9HPTWEU)664BDSE>-_Y_.*L T-%HHJTEZSC
M%"5.M=K7G>]-T4(O&M665NXN2[2R47F-M(LMH,&7M\WK2*<Y,NV0STV0)T*K
M.KUOS7OB42R,<<W-VZ>]L:-+D<#_O 1&7U),+\2E,BVE./-OBXU)M+8U2S^6
MG;'Y]U1WG['K.5-MK-+CH"'H+TLW7?+(3'=JI]EX?2G38BES-:%I=:,.6\<J
MP!9?2=LRKWCYU,$(8[,0NX:J;I-'U9CRXLY^VC4!-9<1YTF=I!G)2EDK\%>E
M93EM-<=7\HGT 6, ;>SIP!6)R6BGAN?@XU1W1MQTO:+)Y(CPK\8S33+ !E/0
M7F6/AKD..D,"W"*7(@5^V27/FDU)KN;&[*UJ%,NG4:!XH^#2ETW:,_?GE1V[
M5*)*.0_4W@J$5)$V3!5,&<-9QZS]N?FE<]_T34:]QK_3;"NJ4KF4Q0+?"E4V
MTC&/K]XO;LGSJ#L86+1F,9^L$97+G7H97YLPB,87>6=]/U)?/EX0X?22J1*M
M;UU/*8W[0LY_&N735R2_V%S(([JJ*QI*JWV#;=%+.FN4I4SKQ;P9SG80E)2]
MM&1*(WU>6/>8=_VX[72[;TFCU[MO??XARO+T.F2F>A,0]N^=-BRA<_V_WSJW
M-\W[96)V!DLM7]9W6?E[?6'H] &HT)J\E&RM#<(4!3"D753(HQ6.2;IGC8;)
M6+XY-?<>U$V-81&T*TXL/C>ZK6L2(?.>I20L'I?3_:5DJU@H+K6LY81_"027
M"ELYW4\Y><SLQC)(]V]:MS^PJFE.^7/*?VP(9IKR_ZO9^OH-;UKCC^9]XVM3
MW*TNZ?SH=7N--A:VS3CUS.S&4MFQ92&-^*PZ^B"]!&8-2][Z5*9<Q2A76EE>
M*S<[#<7V"U % %JAU7UU:$M/+Y>%)WBC&U.7I;C'87ZC3@J@"JU72K0:;U>U
MXQNUVT8OL]/ZE;?]B7?46N6(DZS2TT4JYDU=9E%V'TU=I&+>U6775R7^[*OJ
M]'+?O.ZTKUNW+9[SCFU=OC8:=R2,55G-!((*G6<"P6<:-__SHXL:7_-SJW?3
M2$E_F(3^+^NBV$IM7LBZ_^1]85Z4=A*,#"?8%X9N%DD16UOVP/;$C,>\GTZ:
M>L;D_70.W4\G&[#)\2:U?9AV1LA6!^8.QL^7D<9E',$9[(FJI015/LE@F>#N
MQ8CI2\-RG+>+ J?O50T> LW&'!1 2AZ/L<2I:PU^CN#:,3L60'WDGCY+WW\A
M)G.])<2<LJ>R\\1@RM>Q=ZE(*_&JH1EH9;4J .02K<8SBTZMDQ469UHYM>Z(
MWN3$)+@,>,D3T],RL*\Z5>)5!#*P+ZE$RY6C)MKF)=FR@DJ[*,F6QHV5B[16
MRN+&2C5:4TXSRW[="O?'A/+6C>?2N*MXB?@,;*I>B@4G96!7U=)16UOLAL'G
MO7G2M;&=].9)X\8D$-!JU4SJ,!5:J9]FEYM(>5,VGAC6,V/"U'C55QVFH?41
MQ?Z4$P,LUY]%6J#02KSP00;V)2NT&B^^F(6-E:D<+_9Q>D)!WE@M[9BVB\9J
M:=R7#/O*H@8D47EK'2AEI:H-CTBPO&1U&G:5W=ZWV3RO"BUFP7ZP9GN$$=,>
M4NQ$R-LCG,*>E#JM;&0C2?.FL)G>1DK1D1M9B&8"JO;7U'&Y .!:LRUW@ (\
M,O%;>L&?7>Z9[^ST=G99KFS!AU(@%736Z9!P3'4SDV:HI,X<I\T=)5I3LEB.
M7Z(E95O+];$8_RU[4 WB,-<U&#+W%%_S['**6B9U8YE*]2Q:;;<_K13P]NM
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MDXF-1$DXO< O4263!5B58A8+QDD56LYDQHM,I:W1,#>"9M!VDH,P!V$.P@R
M,*M&T-"^N4J YUJ.\=Q@$")F1:+E<FY92]69E"5:CR<GYF=R;,-:L10+_,@/
MY;@!GG!3E,,=2L!KW_4:GV^;\!G_^_$N>E1B<-+3Q\"SVNR)W%MCU:3B"PK<
MR]:''\A8M1]TF ,?+<Y.ZW?9]B>^^Y1/DI9)@N'_Z^J*?-&9H;TG=^H#8'"7
M_3UEY@!Q2R)75_Y]NVG]X2]$#!\@904Q\&71$N;C>$:NF[>W=XV;FU;[Z^\7
MQ0O^=_>N<>W_/7O10+8SU(D#2_$_!1VGI6)"RVF<9J'LZ%J3I%L1N6W>T(KR
M9A$%\Y\HO5D U0@T?3A^(+WG"2RP8:M]??"!M-4Q$[!N6PA?28J^]<Y_#7]:
M-+WR9JEHCA?<O]P?W\'A)9QCWV;JSZL^&UHVK&C"3]\[6P 6/UC8TMWLL7.L
MBB+IS.C1G> 6!0(=_*K$GQ6X(HCC&K,+0' :.X?U' KWC9MVLT=)JWU=((TV
M'-2/S]W63:MQWVIVC[>L[O6WYLT/N&Z=+Z1Q\S\_NKWF#6DV[MMPS;I\G<$?
M=TVX,-\:]TWR\4NGW9L])=.RQZI!JL7B"FL#5.G^N/MTJ;S]^ X_?'R' WXZ
M'A0N6VW2^];YT84-=TGSW]?-NYZWUYM&K_'VB"N;FBIHA* C)BQBW0NR9*Z]
M3R#N(-GE/_Z:9]<=T(/8O=\;;UD%3!>K&2UVYA)>26Q>;&.Z[B!0VK]?5.8A
MLKI9:(FXZ5/GWLAFC'R'AT<.:9H:TSY^1K'SA@W8N,]L1:*;V9%B\V]H2$K=
MF<@7ZTR01*Z6R6%R45X:$;81T+,!FYB'Z401<F-@;C)^6I9Q</?>2FHW"(CD
M\K;3[;Y%,;'SO4D:O=Y]Z_,/P;5Z'1*5(M/K@,VC2P[NO/#DD4HEKNINY[68
M]8H(^ -J?N^T8>K.]?]^Z]S>-.^["_1/.6DY&QCN?''KS0+2O,2RMH+!SI]!
MV<$402*6$HL;B6QD58O="FEU.;2QMQ&MR3&GSB[AG<=]YG3^V'1^Z1J2*79#
MTXC#8'H5[84IKRQ9*F>QM<S6S5E35*AP'K7\AJ8&KVBNAA7-W^GCB:K;Z0Y;
MS6XJ^/$K9.^!CAESW7-X4(S?1R/]9;.SBVT9Z-&R&.NTO)7S":#@*5<"7XQ[
ML:K@I*%KW//[#91Y>,,AGPM_%,@_U/'D _GG5#5=O<^_2O-)951WR%A-ZGE<
M-"WS:F&S"G*II[CD3]ZPXI2(7B3JV<N#N]0?4XQ=%5JL9%%OK91C7L#L4#,U
M[[V1GEUEDXX][KB/PS$-<SG6G1B-ZT[[0-8&[H8EDD[^6-*XLVVK:1Z;P,W$
MM[R(=*@K#. 4R8.JFV@E<9[4280@7NI+U86LY41>EF+FV$T3(E\=Z*JT+,<D
M["VAESJZ+?,KU+-<T*U#@<$A5\+4>(E7*<5:4)TJF902))D6-R+::1)-5Z?<
MKOJ+H.L./EI#THC@(=#L5T>TX>SCUO*\%,!:$*Q7-PPF/DFY.^WD++/6]Q.*
MW.%?+ L)[G5ZC5LO,^M[L]W#(& ,$TZ(#\[XH61V8VF,15]#9IB+2B=^<#!F
MSRT(#LXXLZM21:KDXL(6$,2R$WMIKGD(ROY*R%9F-[9O>GR,.E-^9O<"T2&2
M6B26.T/)7TCS6$J']E2492MBM'YN084JM8VKX^^,IF<#EF4JRQL74,^I>T[=
MTTW=EY/RBT__:K:^?D-RW/BC>=_XVA3"<I=T?O2ZO48;RQ)D_!0RN['#F Z2
M]+ ;W9BZ3$LO?,LU*E5*M%S.8LWILD+KL+EJ^<1"/],/V9S>')_>K&2J#)2,
MF];MCSEE(Z@=E?'CR.S&CB\VK:$!)X;BO5!)X[0TW9W4&DW DV)!6NKDS(Z.
MNT<H+HU1V5*[W5$AUGBQ-EO<MF)2];:DU?U?PG\VJ[2V_=H#V.)WD>ILZQ7Z
MQ#@'??B,!"IR?MYP15$D;_9L_=(;"T"4D!"3.-\]F]C,X1$6T8P:HCJ.-=!Y
M:NN3[HZ(QHAI/5K$ <[M$*"QC <2B[1$W3+/SR:V;MFP,^*.V)CTV< :8[)B
M)&>GX-TK#Z..#)\5 =02T2B\(#[LC Q&JOG B&Z2H:K;/*B08:P*_H9AA@[1
M1)8F?O'W5+5=9A?.SYJ\PCZ #K]6QQ;L]S\B&-%[5QT,IN.I,?.=F,N9GVS*
M@V,Z\(1-KJTQ'. (SDQ_9-C,U!HS>%?%D]1YB?_HN9R?C9B&(P;'HYML.&1P
MA(\L9<>SXOGTU%]$; 'V.G5P3[)4J"IO>)JL7.(?@8IB;3\R9!CL;O"?'!>P
M^_PLV#Z//0)493Q('HO0B1&*LD0Q 7<B'C.>TP6G>&K2LGL.'ZYPKR9SX?@Y
MPGB)3J+.KO\E/.-U@C@_:\#&ACH0! -PS&4&C,[S0&TV050&H#LB9VH&.+,<
MXQ54HY;S:M2)Z+O;:M1R7HTZW5?E\Z>[QI^=>W)]V^AVR>?[9N-_;SK_:G]\
M]WD'M7[7V9^X0Y\[]Z!9!==GIV*AAV'E<EA0+'X)-Z^_ZPU?*KYY63<)"K&]
M_%@<9$EJ\Q.:9T+"@;?[BS6U00K\IY!GUE3-(_M*7-WZ6E>1JT=>8,<:FXH6
MESW0\A<MY!!&CD\@'8Z9[;%M9\JK<*VQ^"1[<[50?;,'$^"G[TR#-^TMER?+
MA>(NEO<B4-6)[H89DQNOM5ZH[1&2NK8E) OE?0/R7Y;]D]D.UV% @>$@?7<'
MW_ "#RWSKZG]O-TFE(*\%Q!SW6MO1,S/>MW-37OI!'BZSW8@!KDR?N4B<O\I
M"S*+)IF)=)(#L_$N!2AA)B8@1V'T-0A1?Y+OG9O&;:OWY['$J%?2O&"!!'4R
M=<E?/M&C+NV4EW%"!?*3,2!)A$_;$J>&0?YD:KZZ0ZWN&'U(=MM8(U'[VU.'
MD7R+*=OB1LFQI[7%C0H/'/N2[PA,ZP22I%)HR)=QR%B>T%B:<"&^W[<6^=:2
M'E_!V"HE=;U8-2#%'V/I(+XEHU(HO5DTR X6<BI J.5 J 3VEE<,A/).K\-A
M$GBN>YN1XU58Y=9U9JJ!J3130:BPKW)&]Y75\ZILNZ^#IS+<-7OOTGRYRPEL
M,P.XDMEM99)B)8DMJ633_[ZRU><TPS$N^60"/:I9W)92J&=Q6]6"<G)<^H?A
MVJJ#HZ07KI*<39X&^]I:K$OIOC))MF!?Q[W@*W/K[^IX;#W8ZF248IXM[4#X
M2>6^RMNC22KW52E(F=Q7>7MR=?3*IQ>?VM.!P52;\$A'W63I!7@QF^R\F$VI
M5LHHE3X-S7N!PSV,M5W[U9<@GNHZE*4$:3DOY+D6 .,VM!R .08>$H!Q2>OH
ME62S6*<IFH"0+;:=;^PU;FS7Y5;2FT:STTE6RL]7\OS\6=S<2WZ^DN?GI^NJ
M^*EJBBP5N%3U\<>GCY\#Q.+&%"XVC% @^&)9KFFYS/GX[L>^$LV"NB0?NS_N
M@EWCYX-,>"F]%;.1WHCQ_%/5?"8:&^HFC"_:3C&--#^W>C>-\S/5(0 ADS>\
M#VJDP'DQQZ6B3 J%ER<VPXI)O..JJ<T4^:'P_F DB@B)]JO3F=I(#G^#^36"
MO'(LELT;&#K8P9 7[]%T9V(YJH'E?^!6Z1.LN$*)Q2L!>55;X"5\G8JV;?"F
MQOI8# B+M$QU9\2[:5&0#6W>''$RM0<CU6'>3+B,H'LB3N$^PX+#]-Q" )SS
M,P$=G%>LVGL\@!2,/C6Q1A023%Y):FZ_CM?U"_XR#&O@_8)[\X=P+;$: )D-
M!%,4+!* Y^/#"(ZNZ:JMPQ' .<&@NN.UK\-R/P",8#<"PC AD&+=5&U8Z2.O
MA_,TTN%L7,OZ229 Y5FT@!,L6+>TPKZ1<J\<,IAE#J\15("RECG0#?@28*T#
M-$P /H"7G[H*%-X O/O::-P1N!NJR4L)C)GJ3&U6F+\H'/8<X,DOD*D#SZIX
M^*KQS'D9'"(FJ[MP4/UG<J]J;>;"7DR@M+Q?,1X:GL.(J88[POH YV?P"LP*
MYP<K5O&BP*7$PD_X <X+#GV,=0XH\=$AF!]0RX!#MY&.#]2).D!\Y7>UKQOX
M&49TF/VH(Q+ M8GOT!E94P.OB'M^UF=!_V3<5G26<.N1!7E5TQ V--B8[K*Q
MX]]\35"(Q9.2V3GA!NAPNU11@ U@B+ UX'Z8*I:J$O<GJ/)$";\'0\-Z<L@#
M,_$NPB  =^]>F@\4'H7W>$$G&,[;!OR![<D?=5<75$D0G'"3O)06/R^XYRJ6
M@N.EIL0*>2&S*!5(>,\16!'!AH5 1/JF Z71X+S@?&+4&D\<(07+\ Y$+(P!
M6,: )'Q-ZF  5("/QZO;<7SUT 7W)FB\,W4&;.+J< <0DH] ,Q 68^:.+(T3
M*L#@@5>S#1C!"-Z&'VU]0'$_ 12 ,HW5Y_#\_(N%@PI0.OI8-U3;  S47;R,
MWM+Y).(1_IH)!Y 18B3XL.SSX08_-;Q'?>N148XU<WP9)!.;P;>(Q%\ B1'&
M\X=O(!%P>1-34:;#($VL: C8PL%Y^31B 3@-%I0WY#<CP'BFO>78P*=J>0P'
MY$E=*Q!<P_E9N(@E-*\P(V%,D:W/[:+/!BI\/[/C/C;+Q@NLP[2B@[:#+P^G
M2#'Y71!W'CF<N+*6+9AJA'CZ(\,@(3Y-[9#T ?[Y=,"C#4A^\)& (D1N?F%^
MY9K%'$$*;;^ZG ?[@-  9N,ET]W@85]>$'1A$4&R!:_ PH<)-*@ AT+0EB8N
M'BZ8XXCN$<+A_$KQ^FGZ<(A4"[<8/NV(B7#.3%ZS.4 L9"4!^^+@.P+_(G'V
M=7YV%/Y%YMG7^=DQ^!=)9E\H_QR:?Y%$]L6/YY7S+V4U/=+39\[/[@ 2W1&(
ML0C@2 %.3VLCJ@O@[T]=7SP0$C'%PJX%!.$8F]F[UN#GR#(T9J^D-Y)DM?'\
M;!,-D8* C!(THM[ <MR(HHE]FW5;J*3B.[$._ TKX_+RM1ZN^=_/SLII#ZZ&
M JV9.E-<LM#@0$^9VEPK@\=0VQ,U;KU6T1'6^0_;^7MJ?7!X-5?..AT^H5_T
M=&9A@EJU_-JE0A4PGV$9'&5G)T:>Y"T*E$C0AP>"?Z *92/MR[[:Z*OE(18G
MJ9#G9W$=DBQ7(1,'WT:=/#];19\D*ZJ3+R_UP'QUC07,\5ANS'K%.F(,<L!/
M7V:XA](7(R!9P'!?M;Z8X5E>\EB5/I#.A#.:]^16!9J:.[#V[\ J'=2!=2 7
M4RBY9O$.'6:6=Y\[-W]^P@_?>M]O/_U_4$L#!!0    ( .)S859"^Y2Y$48
M ()_ 0 1    <F%D;F5T7V5X.3DP,BYH=&WM?6MS&\F1[7=$X#_TG= X[HT
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M*93_Q)YT5^3>S+I[F.<67W&N%Z[V)!/9A1@Z)3@!626,XQ!/.-[@GNP+T1;
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MQ;?;A5HYC&5RR62;VDVI+$W0N'.M?S9]2E1263G2?(72WS+8'4"UF&\0(<H
M/YU,LP9Y$!5+(41SO>6N1=ONKE^HJ[OS'8VFU]Q3##)IU2,CII^Q[5_96\,%
M9!RG]HH+$AIFG(HKF!U6E!=7NX\P5(\.M\>Z\E_Q_?+*;,;)TY:C_:Y$42))
M)B"M:X4"AZ5Q[MK_G?F!:VE6L_@57K*T/G]*E1TWFH.,F>*-Q&U]!>TMW^?<
M;I<8H&G[- \(.@^$&GG1Q.,G6!0Z J> .U0BC7SQQ+=J:EU=- ^F:,]P$'%.
M&H*AN P=_-C:@>N4HFUJJ3:LA]KZR2ZSM43)!?:4I(LT& B0(IWB0\XXKT>Q
MHL)*A%-,KEW .'/U#C3K @AHZQ) 1 ZV:I$5NA&\6%5(#AP >UD=S%&]FZH2
MS:'C$([& MS;H]!H[)_LR1WOTUL^)OHW.;P/_WWZ\-_D\#[^]Z5?EJ\L_N?5
M?4D_X;HZF]>*L1'5(+(ZUT5R4- *4TE@BW.*!#2@W.?;NL62[I9>J8@E2674
M/.V42$KP2_MW-TM :&IJ71,G42-?E\099@7DLI0D6MW-CHR"C$8+(T45P"2@
MLI0NO[(;?4,9F,_@+KC"#=68=3EODEQR)C6FU\UYBI[3)2()QZ4Y+P2EQ!^&
M]S HXHNK4^R6IWG-"D ; 0!KJPNU1AAO =0$X$(AS_GV?SN:%>EDOLC25U+.
MZO#$Q:6?XHB3H\G<3KS[!'XPE*H($HTNJ2G+/&#^.3O=EW!F@DX7[15IH4Q@
MQ  /B*:XQC8*.6_WWLXX?S-*9K+%=49OYE.&!A<"PBC>*Y*J+!M)VW8THC 3
MHO<X'!713KEXAZ:UL.QH@2]&"@\%_.$F2NG[&WMP<H#'<CD@&#BTO9E&F14A
MI4B-EK[*!1*'C;@0B32Q<7(9YVW>)PR4?@>,B"Z;+=ZTM/F:SM#3?I%H_<MP
ML-IL1[G5;4+DZHF28PSG%T@F9JY2"Z=85^4JJSDRI0"+G*ZP)+/BRGFER4@/
MM34"ZU9Z=#ZI6I]NT%+C?:-N;V8=VR]'D<SY!;?F"<T2LG]X[QDH6B]N:+[E
M2CVRN?<52--$9B)M+27!88:,=V6M=A- 1;S 589F>?A]I57GTCR,TQ0[GV,J
MK71G@8L/)I'G91FG7[A,:&:D\!"C3!\;X.I)T%IH:ZY1T0@S+V^I;10?>E:Q
M-#'Y*/'%3:Z3'Q)+F';$,*P9E+CF3:E0_2C'FTA"BYE5I500# <[6]J?0I"O
M).+O"S03!RBG?18A5,BT"1H ,HM"$OAMPEN3JD*\(024)(R1B2<E4G9<^*][
M"<0/WB#[:%UE ADW$LPY_)J$'=PP'*]PL+L@SK14 +<[YBB=%_.-(NMES$^6
MEBX#1E#GQPR;RDJ0:@VQ=E9I6"BM#.L=@)TKI#>A.#R0!<48ZHJA-E< 5FY6
M(B*=9Z@L#E>TK6, -,U(@YAWA22S@/BD6&<\FL:%.OO7@>O3+/4U'%G$('&*
MK%1WE#L<%I=Y(.,KEZHOAY2 R*%SN>/?4:N<3KAP"OC24.MCXAT3E 2X;H@(
M0\BW=*EQ\>%S&#8^8$&VI9--6+75 IML!1ZG,%_BL+*L Q%] -6 (08Y=1"
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M&@FY%S#N>++!?+](HIZIHBUTBP9DM,F&J0H(#L :0$>I1HOYS.=,LL2[>2Q
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M,SF#"F/P5?#.(,>W%P8TP+C)T!$1$'H#;$(W'(I(5(1^0"H8U:(]G9]EARR
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M971?97@Y.3 Q+FAT;5!+ 0(4 Q0    ( .)S859"^Y2Y$48  ()_ 0 1
M          "  11M  !R861N971?97@Y.3 R+FAT;5!+ 0(4 Q0    ( .)S
M85:/83]J3P,  +,,   1              "  52S  !R9&YT+3(P,C,P,C(X
M+GAS9%!+ 0(4 Q0    ( .)S85:BF^NL_@H  ("&   5              "
M =*V  !R9&YT+3(P,C,P,C(X7VQA8BYX;6Q02P$"% ,4    " #B<V%6#->>
M.58'  #15P  %0              @ $#P@  <F1N="TR,#(S,#(R.%]P<F4N
9>&UL4$L%!@     &  8 ?@$  (S)      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
